Frequencies for first 10,000 rows of dose_vbm variable in drug2004q1 dataset : Verbatim text for dose, frequency, and | route, exactly as entered on report | Freq. Percent Cum. ----------------------------------------+----------------------------------- | 6,936 69.36 69.36 (2 MG/KG, 4 IN 24 HR) | 1 0.01 69.37 (BID), ORAL | 1 0.01 69.38 (WHEN REQUIRED) | 1 0.01 69.39 , 1 IN 1 AS NECESSARY, INTRAVENOUS DRIP | 1 0.01 69.40 , IN 1 AS NECESSARY, INTRAVENOUS DRIP | 1 0.01 69.41 .05 MG, TWICE WEEKLY | 1 0.01 69.42 .05CC WEEKLY | 1 0.01 69.43 .1 MG, QOD | 1 0.01 69.44 .175 MG /DAY ORAL | 1 0.01 69.45 .1MG PER DAY | 1 0.01 69.46 .2 MG, TID | 1 0.01 69.47 .24MG THREE TIMES PER DAY | 1 0.01 69.48 .250MG/DAY ORAL | 1 0.01 69.49 .25MCG PER DAY | 1 0.01 69.50 .25MG PER DAY | 2 0.02 69.52 .3G PER DAY | 1 0.01 69.53 .3MG AS REQUIRED | 1 0.01 69.54 .5MG PER DAY | 2 0.02 69.56 0.1 MG | 1 0.01 69.57 0.1 MG 1 Q WEEK | 1 0.01 69.58 0.1 MG QD PO | 1 0.01 69.59 0.1 MG/DAY | 1 0.01 69.60 0.125 GM Q12H INTRAVENOUS | 1 0.01 69.61 0.125 MG (DAILY), INTRAVENOUS; 0.125 .. | 1 0.01 69.62 0.15 | 1 0.01 69.63 0.15 CC BIW IM | 1 0.01 69.64 0.18 MG/11 DAY | 1 0.01 69.65 0.2 MG (0.1 MG), PO | 1 0.01 69.66 0.2 MG/DAY | 1 0.01 69.67 0.25 MG ONE QID (PO) | 1 0.01 69.68 0.25 MG/1 DAY | 1 0.01 69.69 0.25 MG/DAY | 4 0.04 69.73 0.3 CC BIW IM | 1 0.01 69.74 0.35 CC BIW IM | 1 0.01 69.75 0.4 MG PATCH APPLY @ 6 PM REMOVE @ NOON | 1 0.01 69.76 0.4 MG/DAY X 4 DAYS EVERY 28 DAYS, IV | 1 0.01 69.77 0.41 MG/1 DAY | 1 0.01 69.78 0.45 G/D, ORAL | 2 0.02 69.80 0.5 DOSE 2X PER 1 DAY, ORAL | 1 0.01 69.81 0.5 G/DAY | 1 0.01 69.82 0.5 MG | 1 0.01 69.83 0.5 MG TID | 1 0.01 69.84 0.5 MG, 1 IN 1 DAY, ORAL | 1 0.01 69.85 0.5 ML WEEKLY SUBCUTANEOUS | 1 0.01 69.86 0.5 UG/D | 1 0.01 69.87 0.5MG/DAY | 1 0.01 69.88 0.6 MG (BID), ORAL | 1 0.01 69.89 0.625MG ORAL | 1 0.01 69.90 0.8 | 1 0.01 69.91 0.8 MG/DAY | 1 0.01 69.92 0.8 MG/DAY, ORAL | 1 0.01 69.93 0.8 ML DOSE (FREQUENCY UNSPECIFIED), .. | 1 0.01 69.94 0.8 ML/DAY | 1 0.01 69.95 05-DEC-2003 DISCONTINUED, RESTARTED 1.. | 1 0.01 69.96 1 1 OTHER | 1 0.01 69.97 1 PRN | 1 0.01 69.98 1 ANZ PO | 1 0.01 69.99 1 BOTTLE DAILY ORAL | 1 0.01 70.00 1 CARPULE 1.8 ML LOCAL ANESTHESIA | 1 0.01 70.01 1 DAILY 10 DAYS ORAL | 1 0.01 70.02 1 DAILY BUCCAL | 1 0.01 70.03 1 DAILY ORAL | 4 0.04 70.07 1 DF DAILY ORAL | 1 0.01 70.08 1 DF, ONCE/SINGLE | 1 0.01 70.09 1 DF, QD | 3 0.03 70.12 1 DF, UID/QD, TOPICAL | 1 0.01 70.13 1 DF/D | 2 0.02 70.15 1 DF/DAY | 1 0.01 70.16 1 DOSAGE FORMS, 1 IN 1 D, PER ORAL | 2 0.02 70.18 1 DOSE (S), 1 IN 1 DAY, ORAL | 1 0.01 70.19 1 DOSE (S), 3 IN 4 WEEK, TRANSDERMAL | 1 0.01 70.20 1 DSG FORM/DAY | 1 0.01 70.21 1 EVERY INTRAMUSCULAR | 1 0.01 70.22 1 G | 1 0.01 70.23 1 G IV Q12 H | 1 0.01 70.24 1 G IV Q12HOURS | 1 0.01 70.25 1 G IVP Q24 H | 1 0.01 70.26 1 G PRN PER RECTAL | 1 0.01 70.27 1 G, BID | 1 0.01 70.28 1 G/D | 1 0.01 70.29 1 G/DAY | 1 0.01 70.30 1 G/DAY IVF | 1 0.01 70.31 1 GM Q24H INTRAVENOUS | 1 0.01 70.32 1 GM, 1 IN 1 D, PER ORAL | 1 0.01 70.33 1 GM/KG QD X 2 INTRAVENOUS | 1 0.01 70.34 1 GRAM (QID), ORAL | 1 0.01 70.35 1 GTT OD QID OR MORE | 1 0.01 70.36 1 IN 1 AS NECESSARY, INTRAVENOUS DRIP | 1 0.01 70.37 1 IN 1 AS NECESSARY, INTRAVENOUS; INT.. | 1 0.01 70.38 1 IN 1 D | 1 0.01 70.39 1 IN 1 D PER ORAL | 1 0.01 70.40 1 IN 1 DAY, INTRAVENOUS | 2 0.02 70.42 1 IN 2 WK, SUBCUTANEOUS | 1 0.01 70.43 1 IN 30 D, INTRA-MUSCULAR | 1 0.01 70.44 1 INHALA EVERY 12 H RESPIRATORY | 1 0.01 70.45 1 MG | 1 0.01 70.46 1 MG BID, DAYS 1-5, WKS 1-4, SUBCUTAN.. | 1 0.01 70.47 1 MG DAILY PO | 2 0.02 70.49 1 MG DAY | 2 0.02 70.51 1 MG DOSE; DAILY FREQUENCY NOT SPECIF.. | 1 0.01 70.52 1 MG INTRAVENOUS (NOS) | 1 0.01 70.53 1 MG OTHER | 1 0.01 70.54 1 MG TID PRN PO | 1 0.01 70.55 1 MG, 1 IN 1 DAY, ORAL | 1 0.01 70.56 1 MG, 2 IN 1 DAY, ORAL | 1 0.01 70.57 1 MG, IN 1 DAY, ORAL | 1 0.01 70.58 1 MG, QD | 2 0.02 70.60 1 MG/1 DAY | 1 0.01 70.61 1 MG/DAY | 4 0.04 70.65 1 MG/DAY PO | 1 0.01 70.66 1 PACKET TWICE DAILY, ORAL | 1 0.01 70.67 1 PATCH IMPLANT INTRAPERITONEAL | 1 0.01 70.68 1 PER DAY BUCCAL | 1 0.01 70.69 1 PO PRN | 1 0.01 70.70 1 PUFF 2X DAILY RESPIRATORY | 1 0.01 70.71 1 PUFF BID RESPIRATORY | 1 0.01 70.72 1 QAM 2 QPM | 1 0.01 70.73 1 QD ORAL | 1 0.01 70.74 1 TAB | 1 0.01 70.75 1 TAB DAILY | 2 0.02 70.77 1 TAB MOWEFR ORAL | 1 0.01 70.78 1 TAB PO QD | 1 0.01 70.79 1 TAB QD | 1 0.01 70.80 1 TAB TWICE DAILY | 1 0.01 70.81 1 TAB(S), 1X/DAY, ORAL; 1 TAB(S), 1X/.. | 1 0.01 70.82 1 TAB/DAY ORAL | 1 0.01 70.83 1 TABLET 2X PER 1 DAY; ORAL | 2 0.02 70.85 1 TABLET BID | 1 0.01 70.86 1 TABLET DAILY ORAL | 1 0.01 70.87 1 TABLET DAY | 1 0.01 70.88 1 TABLET EVERY DAY | 2 0.02 70.90 1 TABLET TWICE A DAY (A WEEK OR TWO B.. | 1 0.01 70.91 1 TID | 1 0.01 70.92 1 TO 2 1 OTHER | 1 0.01 70.93 1 U, QD, ORAL | 2 0.02 70.95 1 UNIT, 2 IN 1 D, ORAL | 1 0.01 70.96 1 UNK, QD | 1 0.01 70.97 1 WEEK ORAL | 1 0.01 70.98 1-2 TABLETS QID PRN | 1 0.01 70.99 1-A DAY 10-DAYS | 1 0.01 71.00 1-DAY 10 DAYS | 1 0.01 71.01 1.0 X 10^6 IU/M2, QD, SUBCUTAN. | 1 0.01 71.02 1.1 GM; DAILY; INTRAVENOUS | 1 0.01 71.03 1.2 G/DAY | 1 0.01 71.04 1.2 MG | 1 0.01 71.05 1.25 MG, IN 1 DAY | 1 0.01 71.06 1.25 MG, QD | 2 0.02 71.08 1.4 MG/M2 | 1 0.01 71.09 1.4 MG/M2 IVP ON DAY 3 | 1 0.01 71.10 1.4ML PER DAY | 1 0.01 71.11 1.5 DOSAGE FORMS, 1 IN 1 D, PER ORAL | 1 0.01 71.12 1.5 G/D | 1 0.01 71.13 1.5 GRAM, INTRAVENOUS | 1 0.01 71.14 1.5 MG (1.5 MG,) | 1 0.01 71.15 1.5 MG PO BID | 1 0.01 71.16 1.5 MG/3 DAY | 1 0.01 71.17 1.5 MG/DAY | 1 0.01 71.18 1.5 MG/KG, INTRAVENOUS | 7 0.07 71.25 1.5 MG/KG, NOT REPORTED, INTRAVENOUS | 1 0.01 71.26 1.5G PER DAY | 1 0.01 71.27 1.5MG PER DAY | 1 0.01 71.28 1.71MG PER DAY | 1 0.01 71.29 1.8 GY 5 DOSES 7 WKS | 1 0.01 71.30 1.8 GY/DAY | 1 0.01 71.31 1.8 MG OVER SECONDARY IV X 1 | 1 0.01 71.32 1.9 GM EVERY 48H INTRAVENOUS | 1 0.01 71.33 1/2 TAB BID | 2 0.02 71.35 1/DAY 2 WEEKS ORAL | 1 0.01 71.36 1/WEEK INTRAVENOUS | 1 0.01 71.37 10 DAYS | 1 0.01 71.38 10 G DAILY, TD, 10 G DAILY TD | 1 0.01 71.39 10 G, IN 1 DAY, ORAL | 1 0.01 71.40 10 IU SINGLE INFUSION | 1 0.01 71.41 10 MG | 3 0.03 71.44 10 MG (10 MG,) PER ORAL | 1 0.01 71.45 10 MG (DAILY), ORAL | 5 0.05 71.50 10 MG , PO | 1 0.01 71.51 10 MG 1X PER 1 DAY | 2 0.02 71.53 10 MG 1X PER 1 DAY, ORAL | 1 0.01 71.54 10 MG 1X PER 1 WEEK, ORAL | 1 0.01 71.55 10 MG DAILY | 2 0.02 71.57 10 MG DAILY BY MOUTH | 1 0.01 71.58 10 MG DAILY ORAL | 1 0.01 71.59 10 MG DAILY PO | 3 0.03 71.62 10 MG OD | 1 0.01 71.63 10 MG OD, ORAL | 1 0.01 71.64 10 MG PO | 1 0.01 71.65 10 MG PO Q DAY | 1 0.01 71.66 10 MG QD PO | 9 0.09 71.75 10 MG QID PO | 1 0.01 71.76 10 MG, BID | 2 0.02 71.78 10 MG, ONCE, ORAL | 3 0.03 71.81 10 MG, ORAL | 2 0.02 71.83 10 MG, PER ORAL | 3 0.03 71.86 10 MG, QD | 7 0.07 71.93 10 MG, QD, ORAL | 2 0.02 71.95 10 MG, TID | 1 0.01 71.96 10 MG, TOTAL DAILY, ORAL | 1 0.01 71.97 10 MG, UID/QD, ORAL | 1 0.01 71.98 10 MG, UNK | 1 0.01 71.99 10 MG,QD | 1 0.01 72.00 10 MG/D | 5 0.05 72.05 10 MG/DAY | 3 0.03 72.08 10 MG/DAY PO | 2 0.02 72.10 10 MG; DAILY; INTRAVENOUS | 1 0.01 72.11 10 ML ONCE IM | 1 0.01 72.12 10 ML VIAL | 1 0.01 72.13 10 ML, 1 IN 1 AS NECESSARY, INTRAVENO.. | 1 0.01 72.14 10 U HS SC | 1 0.01 72.15 10 UG/D | 1 0.01 72.16 10 UG/KG/DAY (DAY 10 TO APHERESIS), S.. | 1 0.01 72.17 10.8 MG SC Q 3 MO | 1 0.01 72.18 100 - 600 MG/DAY | 1 0.01 72.19 100 MG | 3 0.03 72.22 100 MG (100 MG,) PER ORAL | 1 0.01 72.23 100 MG (BID), ORAL | 1 0.01 72.24 100 MG (DAILY AT BEDTIME) , ORAL | 1 0.01 72.25 100 MG (DAILY), ORAL | 2 0.02 72.27 100 MG (PRN), ORAL | 1 0.01 72.28 100 MG / DAY | 1 0.01 72.29 100 MG 1X PER 1 DAY | 1 0.01 72.30 100 MG BID | 1 0.01 72.31 100 MG BID, ORAL | 1 0.01 72.32 100 MG DAILY ORAL | 2 0.02 72.34 100 MG DAILY PO | 1 0.01 72.35 100 MG INTRAVENOUS | 1 0.01 72.36 100 MG INTRAVENOUS (NOS) | 1 0.01 72.37 100 MG IV | 1 0.01 72.38 100 MG OD | 1 0.01 72.39 100 MG PO BID | 1 0.01 72.40 100 MG PO BID PRN | 1 0.01 72.41 100 MG PO QD | 1 0.01 72.42 100 MG SQ QD | 1 0.01 72.43 100 MG TWICE DAIL ORAL | 1 0.01 72.44 100 MG, 1 IN 1 AS NECESSARY, INTRAVEN.. | 1 0.01 72.45 100 MG, 2 IN 1 DAY, ORAL | 2 0.02 72.47 100 MG, BID | 1 0.01 72.48 100 MG, CYCLE 2, IV | 1 0.01 72.49 100 MG, DAILY, ORAL | 5 0.05 72.54 100 MG, DAILY, ORAL; 50 MG, DAILY, ORAL | 1 0.01 72.55 100 MG, INTRAVENOUS | 2 0.02 72.57 100 MG, ORAL | 2 0.02 72.59 100 MG, PER ORAL | 1 0.01 72.60 100 MG, QD | 6 0.06 72.66 100 MG, QD, ORAL | 2 0.02 72.68 100 MG, QHS, ORAL | 1 0.01 72.69 100 MG, QID | 1 0.01 72.70 100 MG/D | 3 0.03 72.73 100 MG/DAY | 6 0.06 72.79 100 MG/DAY, ORAL | 1 0.01 72.80 100 MG/M2 INTRAVENOUS | 1 0.01 72.81 100 MG/M2 PO ON DAYS 3-7 | 1 0.01 72.82 100 MG/M2 TWICE DAILY FROM D1 ATO D15.. | 1 0.01 72.83 100 MGS TWICE DAIL ORAL | 1 0.01 72.84 100 ML, SINGLE DOSE, I.A. | 1 0.01 72.85 100 TABS | 1 0.01 72.86 100 TABS PO | 1 0.01 72.87 100 U/DAY | 1 0.01 72.88 100 UG/D | 1 0.01 72.89 100-150 MG, DAILY, ORAL | 1 0.01 72.90 100-50MG/DAY | 1 0.01 72.91 1000 | 1 0.01 72.92 1000 MCG (BID), ORAL | 1 0.01 72.93 1000 MG | 1 0.01 72.94 1000 MG DAILY | 1 0.01 72.95 1000 MG ORALLY | 1 0.01 72.96 1000 MG QD ORAL | 1 0.01 72.97 1000 MG, 1 IN 1 D, ORAL | 2 0.02 72.99 1000 MG/M2 PER INFUSION | 1 0.01 73.00 1000 MG/M2 TWICE A DAY PER ORLA FROM .. | 1 0.01 73.01 1000 MG/M2/OTHER | 1 0.01 73.02 1000 MG/OTHER | 2 0.02 73.04 1000 UNITS QWK IV | 1 0.01 73.05 1000MG | 1 0.01 73.06 1000MG ORAL | 1 0.01 73.07 1000MG PER DAY | 2 0.02 73.09 1000MG/M2 INTRAVENOUS | 1 0.01 73.10 1000MG/M2 TOTAL 1530 MG CONTINUOUS 24.. | 1 0.01 73.11 100MCG TWICE PER DAY | 1 0.01 73.12 100MG ALTERNATE DAYS | 1 0.01 73.13 100MG DAILY; ORAL | 1 0.01 73.14 100MG PER DAY | 16 0.16 73.30 100MG Q AM, ORAL | 1 0.01 73.31 100MG SEE DOSAGE TEXT | 1 0.01 73.32 100MG SINGLE DOSE | 1 0.01 73.33 100MG THREE TIMES PER DAY | 2 0.02 73.35 100MG TWICE PER DAY | 8 0.08 73.43 100MG UNKNOWN | 1 0.01 73.44 100MG/DAY | 1 0.01 73.45 100TAB PER DAY | 1 0.01 73.46 102 MG IN 21 HOURS | 1 0.01 73.47 1038MG DAY 1 AND 8 INTRAVENOUS | 1 0.01 73.48 1050 MG/OTHER | 1 0.01 73.49 107MG PER DAY | 1 0.01 73.50 10CC PER DAY | 1 0.01 73.51 10G PER DAY | 1 0.01 73.52 10MCI OF CARDIOLITE FOR THE RESTING P.. | 1 0.01 73.53 10MG AS REQUIRED | 2 0.02 73.55 10MG DAILY ORAL | 1 0.01 73.56 10MG PER DAY | 20 0.20 73.76 10MG SEVEN TIMES PER DAY | 1 0.01 73.77 10MG TWICE PER DAY | 1 0.01 73.78 10MG UNKNOWN | 1 0.01 73.79 11 MG 1X PER 1 DAY, ORAL | 1 0.01 73.80 11.25 MG (11.25 MG, 1 IN 3 M) INTRAMU.. | 1 0.01 73.81 11.2ML PER DAY | 1 0.01 73.82 1100 MG, 1 IN 1 D, ORAL | 1 0.01 73.83 1100 MG, QD | 1 0.01 73.84 112.5 MG 75 MG | 1 0.01 73.85 1130 Q WK X 2 IV | 1 0.01 73.86 1150 MG PER DAY INTRAVENOUS | 1 0.01 73.87 119.97 MG | 1 0.01 73.88 12 IN, INTRAVENOUS | 1 0.01 73.89 12 MCG BID RESPIRATORY | 1 0.01 73.90 12 MG ONCE PO | 1 0.01 73.91 12.5 MG DAILY IT | 1 0.01 73.92 12.5 MG DAILY PO | 1 0.01 73.93 12.5 MG, 1 IN 1 WEEK, ORAL | 1 0.01 73.94 12.5 MG, LEVEL 3 | 1 0.01 73.95 12.5 TO 15 MG EVERY FOUR WEEKS, INJEC.. | 1 0.01 73.96 12.5 TO 15 MG PER WEEK, ORAL | 1 0.01 73.97 12.5-2500MG QD ORAL | 1 0.01 73.98 12.5MG PER DAY | 1 0.01 73.99 12.5MG/DAY | 3 0.03 74.02 12.7 MG/D | 1 0.01 74.03 120 MG BID IV | 1 0.01 74.04 120 MG BID PO | 1 0.01 74.05 120 MG PO BID | 1 0.01 74.06 120 MG, (BID) | 1 0.01 74.07 120 MG, QD | 2 0.02 74.09 120 MG/DAY | 1 0.01 74.10 1200 MCG HOUR INTRAVENOUS | 1 0.01 74.11 1200 MG | 1 0.01 74.12 1200 MG (BID) | 1 0.01 74.13 1200 MG (BID), INTRAVENOUS | 1 0.01 74.14 1200 MG (QID),ORAL | 1 0.01 74.15 1200 MG (THREE TIMES DAILY), ORAL | 1 0.01 74.16 1200 MG DAILY ORAL | 2 0.02 74.18 1200 MG Q DAY PO | 1 0.01 74.19 1200 MG QD ORAL | 2 0.02 74.21 1200 MG, 1 IN 1 D | 1 0.01 74.22 1200 MG, ONCE/SINGLE | 1 0.01 74.23 1200 MG/D | 1 0.01 74.24 1200 MG/OTHER | 1 0.01 74.25 1200MG PER DAY | 1 0.01 74.26 120MG PER DAY | 1 0.01 74.27 120MG TWICE PER DAY | 1 0.01 74.28 122 MG/Q21 DAYS IV [5 CYCLES] | 1 0.01 74.29 125 MG / DAY | 1 0.01 74.30 125 MG, 1 IN 1 DAY, ORAL | 1 0.01 74.31 125 MG/D | 5 0.05 74.36 125 MG/M2, WEEKS 1,2,4, CYCLIC, IV | 1 0.01 74.37 125 QD ORAL | 1 0.01 74.38 1250 ANTI_XA INTRAVENOUS (NOS) | 1 0.01 74.39 1250 MG QD, ORAL | 1 0.01 74.40 1250 MG/M2 ON DAY 1 AND DAY 8; INTRAV.. | 1 0.01 74.41 1250MG TWICE PER DAY | 1 0.01 74.42 125MCG PER DAY | 1 0.01 74.43 125MG PER DAY | 2 0.02 74.45 125MG TWICE PER DAY | 1 0.01 74.46 1280 MG/1 OTHER | 1 0.01 74.47 12UNIT PER DAY | 1 0.01 74.48 13.5GM CONTINOUS INFUSION X 13 WEEKS | 1 0.01 74.49 130 MG DAILY ORAL | 1 0.01 74.50 130 MG/M2, INTRAVENOUS NOS | 1 0.01 74.51 135MG/M2 IV Q 3 WKS | 1 0.01 74.52 138 MG | 1 0.01 74.53 139MG SEE DOSAGE TEXT | 1 0.01 74.54 14 IU/DAY | 1 0.01 74.55 1400 MG IV QD | 1 0.01 74.56 1400 MG/D (600-0-800 | 1 0.01 74.57 1400 MG/OTHER | 2 0.02 74.59 14000 MG ONCE PO | 1 0.01 74.60 1400MG CUMULATIVE TOTAL | 1 0.01 74.61 140MGD PER DAY | 1 0.01 74.62 1440 MG, | 1 0.01 74.63 145 MG D1 INTRAVENOUS | 1 0.01 74.64 146 MG, CYCLIC, IV | 1 0.01 74.65 15 DROPS/DAY | 1 0.01 74.66 15 MG (15 MG, 1 IN 1 D) | 1 0.01 74.67 15 MG (15 MG,) | 1 0.01 74.68 15 MG 1/ DAY ORAL | 1 0.01 74.69 15 MG DAILY | 2 0.02 74.71 15 MG DAILY ORAL | 1 0.01 74.72 15 MG DAY | 1 0.01 74.73 15 MG IM | 1 0.01 74.74 15 MG ORAL | 2 0.02 74.76 15 MG QW IM | 3 0.03 74.79 15 MG, 1 IN 1 WK, PER ORAL | 1 0.01 74.80 15 MG, QD, IV | 1 0.01 74.81 15 MG, UNK | 1 0.01 74.82 15 MG/AT BEDTIME | 2 0.02 74.84 15 MG/DAY | 9 0.09 74.93 15 MG/KG,QD, INTRAVENOUS | 1 0.01 74.94 15 U/2 DAY | 1 0.01 74.95 15 U/DAY | 2 0.02 74.97 15 U/L IN THE MORNING | 1 0.01 74.98 15,000 U INTRAMUSCULAR | 1 0.01 74.99 15-0-4 IU | 1 0.01 75.00 15.8 MG 1X PER 1 DAY, INTRAVENOUS | 1 0.01 75.01 150 MCG QWK SUBCUTANEOUS | 2 0.02 75.03 150 MG | 1 0.01 75.04 150 MG (DAILY) | 1 0.01 75.05 150 MG , 1 IN 1 DAY | 1 0.01 75.06 150 MG BEGAN 12/5/03 INCREASED TO 300.. | 1 0.01 75.07 150 MG DAILY; 75 MG DAILY | 1 0.01 75.08 150 MG MONTHLY INTRAMUSCULAR | 1 0.01 75.09 150 MG OVER 96 HO INTRAVENOUS | 1 0.01 75.10 150 MG PO | 1 0.01 75.11 150 MG Q 13 WEEKS IM | 1 0.01 75.12 150 MG Q DAY PO | 1 0.01 75.13 150 MG, 1 IN 1 D, ORAL | 1 0.01 75.14 150 MG, DAILY, ORAL | 1 0.01 75.15 150 MG, QD | 1 0.01 75.16 150 MG, QD, ORAL | 1 0.01 75.17 150 MG, QHS | 1 0.01 75.18 150 MG, WKLY X6, IV | 1 0.01 75.19 150 MG/BID, PO | 1 0.01 75.20 150 MG/D | 1 0.01 75.21 150 MG/TWICE PER DAY | 1 0.01 75.22 1500 MG (THREE TIMES A DAY), ORAL | 1 0.01 75.23 1500 MG BID PO | 1 0.01 75.24 1500 MG/DAY | 1 0.01 75.25 1500 ML/DAY | 1 0.01 75.26 1500, QW3 | 1 0.01 75.27 1500IU PER DAY | 1 0.01 75.28 1500MG BID P.O. | 1 0.01 75.29 1500MG PER DAY | 5 0.05 75.34 150MG PER DAY | 9 0.09 75.43 150MG THREE TIMES PER DAY | 1 0.01 75.44 150MG TWICE PER DAY | 22 0.22 75.66 150MG UNKNOWN | 4 0.04 75.70 150TAB FOUR TIMES PER DAY | 1 0.01 75.71 150TAB TWICE PER DAY | 1 0.01 75.72 158 MG/OTHER | 1 0.01 75.73 159 MG/D | 1 0.01 75.74 15DROP PER DAY | 1 0.01 75.75 15MG AT NIGHT | 1 0.01 75.76 15MG PER DAY | 4 0.04 75.80 16 MG (16 MG, 12D/MONTH), IVI | 1 0.01 75.81 16 MG 1X PER 1 DAY, INTRAVENOUS | 1 0.01 75.82 16 MG/DAY | 1 0.01 75.83 16 MIU/DAY | 1 0.01 75.84 16 U/DAY | 1 0.01 75.85 160 MG (BID), | 1 0.01 75.86 160 MG, QD | 4 0.04 75.90 160MG PER DAY | 1 0.01 75.91 160MG TWICE PER DAY | 1 0.01 75.92 165 MG, INTRAVENOUS | 1 0.01 75.93 16MG PER DAY | 1 0.01 75.94 17 MG OVER 2 HRS INTRAVENOUS | 1 0.01 75.95 17 TABS ONCE, ORAL | 1 0.01 75.96 17.5 MG/DAY | 1 0.01 75.97 170MG PER DAY | 2 0.02 75.99 1710MGK SEE DOSAGE TEXT | 1 0.01 76.00 1747.8 MG IV | 1 0.01 76.01 175 MG, BID | 1 0.01 76.02 175 MG/M2 IV Q21D | 1 0.01 76.03 17MG PER DAY | 1 0.01 76.04 18 IU QD SC | 1 0.01 76.05 18 MCG/KG IV QD X5D/3WKS | 1 0.01 76.06 18 MG Q 12 HOURS SQ | 1 0.01 76.07 18 MG, 1 IN 1 DAY, ORAL | 1 0.01 76.08 18 MG/DAY X 4 DAYS EVERY 28 DAYS, IV | 1 0.01 76.09 18 MIU, SUBCUTAN. | 1 0.01 76.10 18 MIU, SUBCUTANEOUS | 1 0.01 76.11 18 MU; QD; SUBCUTANEOUS | 1 0.01 76.12 180 MCG/WK/SQ | 1 0.01 76.13 180 MG, 1X/DAY, INTRAVENOUS | 1 0.01 76.14 180 MG, ORAL | 1 0.01 76.15 180 MG, QD | 1 0.01 76.16 180 MG/D | 1 0.01 76.17 180 MG/DAY PO | 1 0.01 76.18 1800 MG | 1 0.01 76.19 1800 MG 24 HRS. CONT IV | 1 0.01 76.20 1800 MG ONCE PO | 1 0.01 76.21 1800MG PER DAY | 1 0.01 76.22 180MG PER DAY | 1 0.01 76.23 184 MG WEEKLY INTRAVENOUS | 1 0.01 76.24 1840 MG 24 HRS CONT. IV | 1 0.01 76.25 185 ML INTRACORONARY | 1 0.01 76.26 189 MG, 1 IN 1 AS NECESSARY, INTRAVEN.. | 1 0.01 76.27 189MG PER DAY | 1 0.01 76.28 18MG PER DAY | 1 0.01 76.29 19 ML | 1 0.01 76.30 1908 IU/D | 1 0.01 76.31 19U/DAY | 1 0.01 76.32 1G IV Q12H | 1 0.01 76.33 1G PER DAY | 5 0.05 76.38 1G SINGLE DOSE | 2 0.02 76.40 1MG PER DAY | 3 0.03 76.43 1MG PRN ORAL | 1 0.01 76.44 1PUFF TWICE PER DAY | 3 0.03 76.47 1SAC PER DAY | 1 0.01 76.48 1ST COURSE FROM 06- TO 08-OCT-03 | 1 0.01 76.49 1ST DOSE ON 06-OCT-03 | 1 0.01 76.50 1T PO Q4H PRN | 1 0.01 76.51 1TAB PER DAY | 3 0.03 76.54 1TAB SINGLE DOSE | 2 0.02 76.56 1TAB TWICE PER DAY | 1 0.01 76.57 1U PER DAY | 1 0.01 76.58 1UNIT FOUR TIMES PER DAY | 1 0.01 76.59 1UNIT PER DAY | 1 0.01 76.60 1UNIT THREE TIMES PER WEEK | 1 0.01 76.61 1UNIT TWICE PER DAY | 3 0.03 76.64 1^ OINTMENT | 1 0.01 76.65 2 BOXES OF SLEEPGELS, ORAL | 1 0.01 76.66 2 CAPSUL ONCE DAILY ORAL | 1 0.01 76.67 2 DAYS PO | 1 0.01 76.68 2 DF | 1 0.01 76.69 2 DF BID, ORAL | 1 0.01 76.70 2 DF DAILY | 1 0.01 76.71 2 DF, Q4H | 1 0.01 76.72 2 DF/D | 2 0.02 76.74 2 DF/DAY | 1 0.01 76.75 2 DOSES INHALATION | 1 0.01 76.76 2 EVERYDAY YEARS | 1 0.01 76.77 2 G/D | 2 0.02 76.79 2 G/DAY | 1 0.01 76.80 2 GM IV Q 8 H | 1 0.01 76.81 2 GM/M2 3.1 GM | 1 0.01 76.82 2 GM/M2 3.3 GM | 2 0.02 76.84 2 GMS FE DEXTRAN DILUTED 1 MG/ML STAR.. | 1 0.01 76.85 2 GRAM (BID), INTRAVENOUS | 1 0.01 76.86 2 GRAMS Q12 | 1 0.01 76.87 2 IN 1 D, PER ORAL | 1 0.01 76.88 2 LIQUIDCAPS TWO TIMES, ORAL | 1 0.01 76.89 2 MG 1X PER 1 DAY | 1 0.01 76.90 2 MG DAILY ORAL | 1 0.01 76.91 2 MG ON MWR, 4 MG ON OTHER DAYS, CHRO.. | 1 0.01 76.92 2 MG ONE TIME INTRATRACHEAL | 1 0.01 76.93 2 MG TID PO | 1 0.01 76.94 2 MG, 1 IN 1 D, PER ORAL | 2 0.02 76.96 2 MG, 1 IN 3 DAY, ORAL | 1 0.01 76.97 2 MG, 1 IN 4 HOUR, ORAL | 1 0.01 76.98 2 MG, IN 1 DAY, ORAL | 1 0.01 76.99 2 MG/DAY | 2 0.02 77.01 2 MG/DAY, ORAL | 1 0.01 77.02 2 MG/KG, INTRAVENOUS | 1 0.01 77.03 2 MG/OTHER | 1 0.01 77.04 2 ML, ONE TIME, ORAL | 1 0.01 77.05 2 PILLS 24 HOURS ORAL | 1 0.01 77.06 2 PILLS TWICE A DA | 1 0.01 77.07 2 PUFFS Q4 H PRN | 1 0.01 77.08 2 QID | 1 0.01 77.09 2 TABLET BID PO | 2 0.02 77.11 2 TABS = 1000 MG | 1 0.01 77.12 2 TABS PO | 1 0.01 77.13 2 TIMES INTRA-UTERINE | 1 0.01 77.14 2 U/DAY PO | 1 0.01 77.15 2 U/L IN THE MORNING | 1 0.01 77.16 2 X 10 IU INFUSION | 2 0.02 77.18 2 X 500 MG | 1 0.01 77.19 2-3 MCG/KG/H | 2 0.02 77.21 2-3 TABLETS DAILY | 1 0.01 77.22 2-4 TABS PO | 2 0.02 77.24 2-5 ML IC | 1 0.01 77.25 2.1G PER DAY | 1 0.01 77.26 2.3 MG BIW: INTRAVENOUS | 1 0.01 77.27 2.5 G/DAY | 1 0.01 77.28 2.5 MG | 2 0.02 77.30 2.5 MG 1 IN 1 WK ,ORAL | 1 0.01 77.31 2.5 MG 1 X PER 1 DAY | 1 0.01 77.32 2.5 MG 1X MER 1 DAY/ORAL | 1 0.01 77.33 2.5 MG 2X PER 1 WEEK, ORAL | 1 0.01 77.34 2.5 MG DAILY, ORAL | 3 0.03 77.37 2.5 MG OD | 1 0.01 77.38 2.5 MG ONCE | 1 0.01 77.39 2.5 MG PO QD | 1 0.01 77.40 2.5 MG QD - SUBCUTANEOUS | 1 0.01 77.41 2.5 MG, 1 IN 3 DAY, TRANSDERMAL | 1 0.01 77.42 2.5 MG, 1 IN 3 DAY, TRANSDERMAL; 5 MG.. | 1 0.01 77.43 2.5 MG, QD | 1 0.01 77.44 2.5 MG/1 AT BEDTIME | 1 0.01 77.45 2.5 MG/DAY | 3 0.03 77.48 2.5 MG/DAY IV | 1 0.01 77.49 2.5 MG/IN THE EVNEING | 1 0.01 77.50 2.5 MG: INTRAVENOUS (NOT OTHERWISE SP.. | 1 0.01 77.51 2.5 TO 20 MG WEEKLY, ORAL | 1 0.01 77.52 2.5%, 5-7 MG/KG, INTRAVENOUS | 7 0.07 77.59 2.5%, 5-7 MG/KG, NOT REPORTED, INTRAV.. | 1 0.01 77.60 2.5-7.5 MCG/KG/H | 1 0.01 77.61 2.5G PER DAY | 1 0.01 77.62 2.5MG TWICE PER DAY | 1 0.01 77.63 2.7 GM EVERY 12H INTRAVENOUS | 1 0.01 77.64 2.8 GM/M2 3.975 GM D | 1 0.01 77.65 2/27/2002-400MG, 3/8/2002-300 MG | 1 0.01 77.66 20 GTT PRN | 1 0.01 77.67 20 M 1 X PER 1 DAY | 1 0.01 77.68 20 MCG QD SUBCUTANEOUS | 1 0.01 77.69 20 MF/D | 1 0.01 77.70 20 MG | 5 0.05 77.75 20 MG (20 MG, 1 IN 1 D) PER ORAL | 1 0.01 77.76 20 MG (DAILY), ORAL | 5 0.05 77.81 20 MG -14- 3X''S DAI ORAL | 1 0.01 77.82 20 MG 1PO/D | 1 0.01 77.83 20 MG 1X PER 1 DAY | 1 0.01 77.84 20 MG 1X PER 1 DAY ORAL | 1 0.01 77.85 20 MG 1X PER 1 DAY, INTRAVENOUS; 19 M.. | 1 0.01 77.86 20 MG 1X PER 1 WEEK, ORAL | 1 0.01 77.87 20 MG BID PO | 2 0.02 77.89 20 MG DAILY ORAL | 1 0.01 77.90 20 MG DAILY PO | 3 0.03 77.93 20 MG DAILY PO PTA | 1 0.01 77.94 20 MG DAY ORAL | 1 0.01 77.95 20 MG ONCE A DAY, 10 MG ONCE A DAY | 1 0.01 77.96 20 MG ONCE ORAL | 1 0.01 77.97 20 MG ONCE PER D, 30 MG ONCE PER D | 1 0.01 77.98 20 MG PO BID | 2 0.02 78.00 20 MG PO QAM/40 MG PO QPM | 1 0.01 78.01 20 MG PO QD | 1 0.01 78.02 20 MG PO QPM | 1 0.01 78.03 20 MG QD ORAL | 1 0.01 78.04 20 MG QD PO | 6 0.06 78.10 20 MG THREE QD | 2 0.02 78.12 20 MG TID | 1 0.01 78.13 20 MG TWICE DAILY ORAL | 1 0.01 78.14 20 MG, 1 IN 1 WEEK | 1 0.01 78.15 20 MG, BID | 1 0.01 78.16 20 MG, ONCE/SINGLE | 2 0.02 78.18 20 MG, ORAL | 3 0.03 78.21 20 MG, PER ORAL | 1 0.01 78.22 20 MG, QD | 1 0.01 78.23 20 MG, QD, ORAL | 1 0.01 78.24 20 MG, UNK | 2 0.02 78.26 20 MG,L QD, ORAL | 1 0.01 78.27 20 MG-40 MG 1 TABLET | 1 0.01 78.28 20 MG/AS NEEDED | 1 0.01 78.29 20 MG/D | 1 0.01 78.30 20 MG/DAY | 9 0.09 78.39 20 MG/DAY A FEW YEARS | 1 0.01 78.40 20 MG/M2 FOR 5 DAYS/WEEKLY | 1 0.01 78.41 20 MGS 3 TIMES | 2 0.02 78.43 20 MILLIGRAM | 1 0.01 78.44 20 ML IV X 1 DOSE | 1 0.01 78.45 20 ML, 1 ONLY FOR 1 DAY, ORAL | 1 0.01 78.46 20 ML/DAY | 1 0.01 78.47 20 ML/KG/D | 1 0.01 78.48 20 QHS | 1 0.01 78.49 20 TABLETS, SINGLE, ORAL | 2 0.02 78.51 20 U QD | 1 0.01 78.52 20 U/3 DAY | 1 0.01 78.53 20 U/DAY | 2 0.02 78.55 20 UG QD IN | 2 0.02 78.57 20 UG, CONT, INTRA-UTERINE | 3 0.03 78.60 20 UG./DAY | 1 0.01 78.61 20 UG/DAY | 6 0.06 78.67 20, QD | 1 0.01 78.68 20,000 U INTRAMUSCULAR | 3 0.03 78.71 200 MCG, SC | 1 0.01 78.72 200 MG | 5 0.05 78.77 200 MG (100 MG, 2 IN 1 D) | 1 0.01 78.78 200 MG (200 MG, 1 IN 1 D) | 1 0.01 78.79 200 MG (BID), INTRAVENOUS | 1 0.01 78.80 200 MG (DAILY), INTRAVENOUS | 2 0.02 78.82 200 MG (QID), ORAL | 2 0.02 78.84 200 MG 1X PER 1 DAY; ORAL | 1 0.01 78.85 200 MG 1X PER 8 WK, INTRAVENOUS | 1 0.01 78.86 200 MG BID ORAL | 3 0.03 78.89 200 MG DAILY | 1 0.01 78.90 200 MG DAILY ORAL | 1 0.01 78.91 200 MG DAILY PO | 1 0.01 78.92 200 MG HS ORAL | 1 0.01 78.93 200 MG OD, ORAL | 1 0.01 78.94 200 MG PER DAY | 1 0.01 78.95 200 MG PO BID | 1 0.01 78.96 200 MG PO QD | 2 0.02 78.98 200 MG PO STARTED AT 9/24/03 | 1 0.01 78.99 200 MG, 1 IN 1 D | 1 0.01 79.00 200 MG, 1 IN 1 D, ORAL | 1 0.01 79.01 200 MG, 1 IN 1 D, PER ORAL | 1 0.01 79.02 200 MG, 1 IN 1 DAY, INTRAVENOUS | 1 0.01 79.03 200 MG, 1 IN 1 DAY, ORAL | 2 0.02 79.05 200 MG, 11 IN 2 MONTH, INTRAVENOUS DRIP | 1 0.01 79.06 200 MG, 2 IN 1 D, PER ORAL | 1 0.01 79.07 200 MG, 2 IN 1 DAY | 1 0.01 79.08 200 MG, 2 IN 1 DAY, ORAL | 2 0.02 79.10 200 MG, BID | 3 0.03 79.13 200 MG, CYCLE 2, IV | 1 0.01 79.14 200 MG, DAILY, ORAL | 5 0.05 79.19 200 MG, IN 1 DAY, ORAL | 1 0.01 79.20 200 MG, INTRAVENOUS | 4 0.04 79.24 200 MG, ORAL | 3 0.03 79.27 200 MG, ORAL 3 | 1 0.01 79.28 200 MG, QD | 3 0.03 79.31 200 MG, QHS, ORAL | 1 0.01 79.32 200 MG, TID | 2 0.02 79.34 200 MG/D | 7 0.07 79.41 200 MG/DAY | 12 0.12 79.53 200 MG/M2 Q 6 WEEKS IV 190MG (50% PER.. | 1 0.01 79.54 200 MG/M2, ONCE INTRAVENOUS | 1 0.01 79.55 200 MG/M2, ONCE INTRAVENOUS BOLUS | 1 0.01 79.56 200 MG/M2, ONCE, INTRAVENOUS | 1 0.01 79.57 200 MG/M2, ONCE, INTRAVENOUS | 21 0.21 79.78 200 MG/M2, ONCE, INTRAVENOUS; SEE IMAGE | 1 0.01 79.79 200 UG/HR, 1 IN 72 HOUR, TRANSDERMAL | 1 0.01 79.80 200 UNK, BID | 1 0.01 79.81 200-100 MG, DAILY, ORAL | 1 0.01 79.82 2000 MG (2000 MG), IVI | 1 0.01 79.83 2000 MG, CYCLIC, IV | 1 0.01 79.84 2000 MG/M2 IV IN 1 LITER NS OVER 2 HO.. | 1 0.01 79.85 2000 TWICE A DAY PER ORAL FROM D1 TO .. | 1 0.01 79.86 20000 U, 3 TIMES/WK, SC | 1 0.01 79.87 20000 U, WEEKLY, SC | 1 0.01 79.88 2000MG/DAY | 1 0.01 79.89 200MCG PER DAY | 1 0.01 79.90 200MG HS ORAL | 1 0.01 79.91 200MG PER DAY | 11 0.11 80.02 200MG THREE TIMES PER DAY | 1 0.01 80.03 200MG TWICE PER DAY | 5 0.05 80.08 200MG/DAY | 1 0.01 80.09 200MG/M2 IV Q 3 WKS | 1 0.01 80.10 201 MG, 1 IN 1 AS NECESSARY, INTRAVEN.. | 1 0.01 80.11 2050 UNITS IM | 1 0.01 80.12 20MG DAY ORAL | 1 0.01 80.13 20MG EIGHT TIMES PER DAY | 1 0.01 80.14 20MG PER DAY | 15 0.15 80.29 20MG PO BID | 1 0.01 80.30 20MG PO QD | 1 0.01 80.31 20MG UNKNOWN | 1 0.01 80.32 210 MG (NR, IN THE MORINING AND AT NI.. | 1 0.01 80.33 210 MG, INTRAVENOUS | 1 0.01 80.34 2100 MG, | 1 0.01 80.35 211 MG Q2W - INTRAVENOUS NOS | 1 0.01 80.36 2150 MG/1WEEK ORAL | 1 0.01 80.37 216 MG X QWK X 3 IV | 1 0.01 80.38 2170 MG QWK FOR 3 WKS IV | 1 0.01 80.39 22 MG, 1X/DAY, INTRAVENOUS | 1 0.01 80.40 22 MG/D | 1 0.01 80.41 22 U, QD, SUBCUTANEOUS | 1 0.01 80.42 22 U/DAY | 1 0.01 80.43 220 MG Q3W - INTRAVENOUS NOS | 1 0.01 80.44 220 MG, BID, ORAL | 1 0.01 80.45 220 MG, QD, ORAL | 1 0.01 80.46 220 UG/DAY INH | 1 0.01 80.47 225 MG, CYCLE 3, IV | 1 0.01 80.48 225 MG, ORAL; UNKNOWN REDUCED DOSE | 1 0.01 80.49 225 MG, TID | 3 0.03 80.52 225 MG/D | 1 0.01 80.53 225 MG/M2 | 1 0.01 80.54 2250 IU ONCE INTRAMUSCULAR | 1 0.01 80.55 225MG, FREQUENCY UNSPECIFIED; UNKNOWN.. | 1 0.01 80.56 2275 MG AS 46 HOUR INFUSION,Q2W, INTR.. | 1 0.01 80.57 23 TABLETS DISPENSED. | 1 0.01 80.58 24 ML/DAY | 1 0.01 80.59 24 UG/KG/HR | 2 0.02 80.61 24 UG/KG/HR OTHER | 1 0.01 80.62 24 UG/KG/HR/ OTHER | 1 0.01 80.63 24 UG/KG/HR/OTHER | 1 0.01 80.64 240 MG BID PO | 1 0.01 80.65 240 MG, 1 IN 1 AS NECESSARY, INJECTIO.. | 1 0.01 80.66 240 MG, 3 IN 1 D, PER ORAL | 1 0.01 80.67 240 MG, PER ORAL | 1 0.01 80.68 240 MG, QD | 1 0.01 80.69 245 MG Q2W, INTRAVENOUS NOS | 1 0.01 80.70 24MG PER DAY | 3 0.03 80.73 25 1 ORAL | 1 0.01 80.74 25 IU, QD | 1 0.01 80.75 25 MG | 5 0.05 80.80 25 MG 2X /WEEK SQ | 1 0.01 80.81 25 MG (DAILY), ORAL | 1 0.01 80.82 25 MG 1 ORAL | 1 0.01 80.83 25 MG 1/DAY ORAL | 1 0.01 80.84 25 MG 2 X PER 1 WK, SC | 2 0.02 80.86 25 MG 2X PER 1 WK-SC | 1 0.01 80.87 25 MG BID PO | 1 0.01 80.88 25 MG DAILY PO | 2 0.02 80.90 25 MG ONCE DAILY | 1 0.01 80.91 25 MG ONCE PO | 1 0.01 80.92 25 MG PO BID; INCREASED TO 50 MG PO B.. | 1 0.01 80.93 25 MG PO TID | 1 0.01 80.94 25 MG Q HS ORAL | 1 0.01 80.95 25 MG, 1 IN 2 WEEK, INTRA-MUSCULAR; 3.. | 1 0.01 80.96 25 MG, 3 IN 1D, ORAL | 1 0.01 80.97 25 MG, LEVEL 4 + 5 | 1 0.01 80.98 25 MG, ONCE/SINGLE | 1 0.01 80.99 25 MG, Q72H | 1 0.01 81.00 25 MG, QD | 3 0.03 81.03 25 MG, QD, ORAL | 1 0.01 81.04 25 MG, TID | 1 0.01 81.05 25 MG, TWICE WEEKLY, SC | 1 0.01 81.06 25 MG, TWICE WEEKLY, SUBCUTANEOUS | 1 0.01 81.07 25 MG/ 24-48 HOURS | 1 0.01 81.08 25 MG/D | 1 0.01 81.09 25 MG/DAY | 7 0.07 81.16 25 TABLETS, ONCE/SINGLE | 2 0.02 81.18 25 U/2 DAY | 1 0.01 81.19 25 U/DAYS | 1 0.01 81.20 25 UG/HR, TRANSDERMAL | 1 0.01 81.21 25-300MG QD ORAL | 1 0.01 81.22 25.0-25 MG PO | 1 0.01 81.23 250 MCG (BID), ORAL | 1 0.01 81.24 250 MG (DAILY), ORAL | 1 0.01 81.25 250 MG (Q48 H), INTRAVENOUS | 1 0.01 81.26 250 MG DAILY | 1 0.01 81.27 250 MG DAILY PO | 17 0.17 81.44 250 MG PER DAY | 1 0.01 81.45 250 MG PO | 1 0.01 81.46 250 MG QD PO | 3 0.03 81.49 250 MG, IN 1 DAY, ORAL | 1 0.01 81.50 250 MG, ORAL | 1 0.01 81.51 250 MG, QD | 7 0.07 81.58 250 MG, UNK | 1 0.01 81.59 250 MG/D | 1 0.01 81.60 250 MG/DAY | 1 0.01 81.61 250 MG/FOUR TIMES PER DAY/INTRAV | 1 0.01 81.62 250 MG/M2 X 1 DOSE (DAY 2), INTRAVENOUS | 1 0.01 81.63 250 MG/M2, 1 X/DAY, INTRAVENOUS | 1 0.01 81.64 250/50 UG | 1 0.01 81.65 2500 ANTI_XA INTRAVENOUS (NOS) | 1 0.01 81.66 250MCG PER DAY | 2 0.02 81.68 250MG TWICE PER DAY | 3 0.03 81.71 25MG AT NIGHT | 1 0.01 81.72 25MG DAILY ORAL | 1 0.01 81.73 25MG PER DAY | 12 0.12 81.85 25MG Q AM, ORAL | 1 0.01 81.86 25MG/DAY | 3 0.03 81.89 25MGM2 WEEKLY | 1 0.01 81.90 26 MG, 1 IN 1 D, ORAL | 1 0.01 81.91 26 MG/D | 1 0.01 81.92 26 U HS SC | 1 0.01 81.93 26 U/DAY | 1 0.01 81.94 260 MG INTRAVENOUS NOS | 1 0.01 81.95 265 MG/D | 1 0.01 81.96 267 MG, INTRAVENOUS | 1 0.01 81.97 27.5 MG/M2, IV 1 HR | 1 0.01 81.98 270 MG/DAY | 1 0.01 81.99 285 MG, CYCLIC, IV | 1 0.01 82.00 290 MG Q3W, INTRAVENOUS NOS | 1 0.01 82.01 2G PER DAY | 4 0.04 82.05 2MG PER DAY | 7 0.07 82.12 2MGM2 WEEKLY | 1 0.01 82.13 2SAC PER DAY | 1 0.01 82.14 2TAB PER DAY | 1 0.01 82.15 2TAB TWICE PER DAY | 1 0.01 82.16 2U MONTHLY | 1 0.01 82.17 2U PER DAY | 1 0.01 82.18 2UNIT PER DAY | 2 0.02 82.20 2X DAILY ORAL | 1 0.01 82.21 2X40 MG | 1 0.01 82.22 2XY PO | 1 0.01 82.23 3 BOTTLE ONCE PO | 1 0.01 82.24 3 CAPSULE, 1 IN 1 D, PER ORAL | 1 0.01 82.25 3 CAPSULE, 2 IN 1 D, PER ORAL | 2 0.02 82.27 3 DF DAILY | 2 0.02 82.29 3 DF/D | 3 0.03 82.32 3 DF/DAY | 12 0.12 82.44 3 DOSAGE FORMS, 2 IN 1 D | 1 0.01 82.45 3 DOSE(S), ORAL | 1 0.01 82.46 3 G ORALLY | 1 0.01 82.47 3 G/DAY | 1 0.01 82.48 3 G/M2/D 12 HOURS INTRAVENOUS | 1 0.01 82.49 3 GRAM (BID), INTRAVENOUS | 1 0.01 82.50 3 IU, UNK | 1 0.01 82.51 3 MG, BID | 1 0.01 82.52 3 MG/D | 1 0.01 82.53 3 MG/DAY | 1 0.01 82.54 3 MG/KG INTRAVENOUS | 2 0.02 82.56 3 MG/KG, 1 IN 1 AS NECESSARY, INTRAVE.. | 1 0.01 82.57 3 MG/KG, 1 IN 8 WEEK, INTRAVENOUS | 1 0.01 82.58 3 MG/KG, 13 IN , INTRAVENOUS DRIP | 1 0.01 82.59 3 MG/KG, 1IN 1 AS NECESSARY, INTRAVEN.. | 1 0.01 82.60 3 MG/KG, INTRAVENOUS | 3 0.03 82.63 3 MG/KG, INTRAVENOUS; 3 MG/KG, 1 IN 1.. | 1 0.01 82.64 3 MG/KG, OM, INTRAVENOUS | 2 0.02 82.66 3 MG/KG/D | 1 0.01 82.67 3 MG/KG/DAY | 1 0.01 82.68 3 ML/KG/HOUR | 1 0.01 82.69 3 MU QD SC; 6 MU QOD SC; 3 MU QOD SC;.. | 1 0.01 82.70 3 TABS BID | 1 0.01 82.71 3 TIMES A WEEK | 1 0.01 82.72 3.37 G IV Q 6 H | 1 0.01 82.73 3.375G IV Q6H | 1 0.01 82.74 3.5 MG 2ND INJECT INTRAMUSCULAR | 1 0.01 82.75 3.75 MG (3.75 MG, 1 IN 28 D) SUBCUTAN.. | 3 0.03 82.78 3.75 MG Q4WK SQ | 1 0.01 82.79 3.75 MG/D | 1 0.01 82.80 3.75MG/DAY | 1 0.01 82.81 3.85 G/DAY PO | 1 0.01 82.82 30 IU, QD | 1 0.01 82.83 30 MCG BIW IM | 2 0.02 82.85 30 MCG QW IM | 1 0.01 82.86 30 MCG QW IM | 117 1.17 84.03 30 MCQ QW IM | 1 0.01 84.04 30 MG | 1 0.01 84.05 30 MG (30 MG, 1 IN 1 D) | 1 0.01 84.06 30 MG (30 MG, 1 IN 1 D) PER ORAL | 2 0.02 84.08 30 MG 1 X ORAL | 1 0.01 84.09 30 MG DAILY ORAL | 1 0.01 84.10 30 MG DAILY PO | 1 0.01 84.11 30 MG IV Q 3 MONTHS | 1 0.01 84.12 30 MG IVP Q 6 H | 1 0.01 84.13 30 MG ONCE DAILY ORAL | 1 0.01 84.14 30 MG PO PO | 1 0.01 84.15 30 MG QD ORAL | 1 0.01 84.16 30 MG, 1 IN 1 D, PER ORAL | 2 0.02 84.18 30 MG, 1 IN 24 HOUR, ORAL | 1 0.01 84.19 30 MG, ONCE/SINGLE | 1 0.01 84.20 30 MG, QD | 2 0.02 84.22 30 MG, TID | 3 0.03 84.25 30 MG/45 MG/30 MG ORAL | 1 0.01 84.26 30 MG/D | 4 0.04 84.30 30 MG/DAY | 1 0.01 84.31 30 MG/DAY, ORAL | 1 0.01 84.32 30 MG/M2, 1/DAY, INTRAVENOUS | 1 0.01 84.33 30 MG/M2, CYCLIC, IV | 1 0.01 84.34 30 MG/M2, WEEKLY, IV | 1 0.01 84.35 30 MG/MM^2 | 1 0.01 84.36 30 U/2 DAY | 1 0.01 84.37 30 U/4 DAY | 1 0.01 84.38 30 U/DAY | 1 0.01 84.39 300 MG (DAILY), ORAL | 2 0.02 84.41 300 MG 2X PER 1 DAY; INTRAVENOUS | 1 0.01 84.42 300 MG DAILY | 3 0.03 84.45 300 MG DAILY PO | 3 0.03 84.48 300 MG EACH DAY ORAL | 1 0.01 84.49 300 MG PO | 2 0.02 84.51 300 MG PO 7 DAYS, THEN 300 MG, TID 7 .. | 1 0.01 84.52 300 MG Q HS, ORAL | 1 0.01 84.53 300 MG QD ORAL | 1 0.01 84.54 300 MG QD PO | 6 0.06 84.60 300 MG QHS ORAL | 1 0.01 84.61 300 MG, 1 IN 1 AS NECESSARY, INTRAVEN.. | 1 0.01 84.62 300 MG, 1 IN 1 DAY | 1 0.01 84.63 300 MG, 1 IN 1 TOTAL, INTRAVENOUS | 1 0.01 84.64 300 MG, 1 IN 8 WEEK, INTRAVENOUS | 1 0.01 84.65 300 MG, 3 IN 1 DAY, ORAL | 1 0.01 84.66 300 MG, DAILY, ORAL | 2 0.02 84.68 300 MG, INTRAVENOUS | 2 0.02 84.70 300 MG, ORAL | 3 0.03 84.73 300 MG, Q2W, SUBCUTANEOUS | 1 0.01 84.74 300 MG, QD | 1 0.01 84.75 300 MG, SSRI | 1 0.01 84.76 300 MG, UNK | 2 0.02 84.78 300 MG/D | 5 0.05 84.83 300 MG/DAY | 5 0.05 84.88 300 MG/M2 IV OVER 4 HOURS ON DAY 2 | 1 0.01 84.89 300 MG/TWICE PER DAY | 1 0.01 84.90 3000 MG ORALLY | 1 0.01 84.91 3000 MG, 1 IN 1 D, ORAL; 1500 MG, 1 I.. | 1 0.01 84.92 3000 MG/DAY | 1 0.01 84.93 3000MG PER DAY | 3 0.03 84.96 300MG PER DAY | 18 0.18 85.14 300MG SEE DOSAGE TEXT | 1 0.01 85.15 300MG TWICE PER DAY | 1 0.01 85.16 300MG VARIABLE DOSE | 1 0.01 85.17 30MG AT NIGHT | 1 0.01 85.18 30MG DAILY ORAL | 1 0.01 85.19 30MG PER DAY | 4 0.04 85.23 30MG/M2 DAYS 1 AND INTRAVENOUS | 1 0.01 85.24 32 NG/KG/MIN CONTINUOUS IV | 1 0.01 85.25 320 MG/DAY IV | 1 0.01 85.26 320 MG/OTHER | 1 0.01 85.27 3200 MG (DAILY), ORAL | 1 0.01 85.28 325 MG, QD | 1 0.01 85.29 325MG PER DAY | 1 0.01 85.30 34 U QD SC | 1 0.01 85.31 3400 MG, CYCLE 3, IV | 1 0.01 85.32 35 GM Q 3WEEKS INTRAVENOUS | 1 0.01 85.33 35 MG ONCE WEEKLY, ORAL | 1 0.01 85.34 35 U/DAY | 1 0.01 85.35 35.8 MCI INJECTION RECEIVED 20/NOV/02.. | 1 0.01 85.36 350 MG / DAY | 1 0.01 85.37 350 MG DAILY DOSE | 3 0.03 85.40 350 MG ONCE PO | 1 0.01 85.41 350 MG Q 8 HOURS | 2 0.02 85.43 350 MG/ DAY, ORAL | 1 0.01 85.44 350 MG/M2 | 1 0.01 85.45 3500 UNITS Q8 SUBCUTANEOUS | 1 0.01 85.46 350MG OVERDOSE | 1 0.01 85.47 35MG SINGLE DOSE | 1 0.01 85.48 36 IU, QD | 1 0.01 85.49 36 MG 24 HRS. CONT IV | 1 0.01 85.50 36 MG ORAL | 1 0.01 85.51 36 MG, 1 IN 1 DAY, ORAL | 1 0.01 85.52 36 MG, ORAL | 1 0.01 85.53 36 U HS SC | 1 0.01 85.54 36.85 GM;Q3W;INTRAVENOUS | 1 0.01 85.55 36.9 GM;Q3W;INTRAVENOUS | 1 0.01 85.56 360 MG, ONCE/SINGLE, ORAL | 1 0.01 85.57 3600 MG (DAILY) | 1 0.01 85.58 3600 MG (TID) | 1 0.01 85.59 3600 MG (TID), ORAL | 1 0.01 85.60 3600 MG ONCE PO | 1 0.01 85.61 360MG Q8 IV | 1 0.01 85.62 362.5 MG, INTRAVENOUS | 1 0.01 85.63 37 MG 24 HRS. CONT. IV | 1 0.01 85.64 37.5 MG 1X PER 1 DAY ORAL | 1 0.01 85.65 37.5 MG, QD | 1 0.01 85.66 37.5 MG/DAY | 1 0.01 85.67 37.5MG TWICE PER DAY | 1 0.01 85.68 37.5MG/DAY | 1 0.01 85.69 375 MG, Q2W, SUBCUTANEOUS | 1 0.01 85.70 375 MG, QD | 1 0.01 85.71 375 MG/D | 2 0.02 85.73 375 MG/M2 IV ON DAY 1 | 1 0.01 85.74 3750 IU IVPB | 1 0.01 85.75 38 MG/1 OTHER | 1 0.01 85.76 3G PER DAY | 7 0.07 85.83 3H61268/3H61268 11/5 590 MG 3F69234/.. | 1 0.01 85.84 3KIU PER DAY | 1 0.01 85.85 3Z PER DAY | 1 0.01 85.86 4 DF/D | 2 0.02 85.88 4 DF/DAY | 1 0.01 85.89 4 G BID IV | 1 0.01 85.90 4 G/DAY | 1 0.01 85.91 4 GM/M2 (3 DIVIDED DOSES, DAY 1) | 1 0.01 85.92 4 GM/M2 X 1 DOSE (DAY 1), INTRAVENOUS | 1 0.01 85.93 4 IN 1 DAY | 1 0.01 85.94 4 MG | 2 0.02 85.96 4 MG (2 MG, 2 IN 1 D) | 1 0.01 85.97 4 MG (DAILY), ORAL | 1 0.01 85.98 4 MG 1X PER 1 WEEK, ORAL | 1 0.01 85.99 4 MG 1X PER 1 WK, ORAL | 1 0.01 86.00 4 MG 2X PER 1 DAY | 1 0.01 86.01 4 MG BID ORAL | 1 0.01 86.02 4 MG BID PO | 1 0.01 86.03 4 MG DAILY AT TIME OF EVENT ONSET, ORAL | 1 0.01 86.04 4 MG DAILY PO | 1 0.01 86.05 4 MG OD | 1 0.01 86.06 4 MG ONCE/2 MG ONCE INTRAVENOUS (NOS) | 1 0.01 86.07 4 MG QD | 1 0.01 86.08 4 MG QD PO | 3 0.03 86.11 4 MG, EVERY MONTH | 1 0.01 86.12 4 MG, ONCE/SINGLE | 1 0.01 86.13 4 MG, QD | 2 0.02 86.15 4 MG, QMO | 2 0.02 86.17 4 MG, TIW | 2 0.02 86.19 4 MG/D | 1 0.01 86.20 4 MG/DAY | 4 0.04 86.24 4 MG/KG, INTRAVENOUS | 1 0.01 86.25 4 TO 8 MG PO AT BEDTIME ORAL | 1 0.01 86.26 4 U/DAY PO | 1 0.01 86.27 4 U/DAY PO/ A FEW MONTHS | 1 0.01 86.28 4 UNIT | 1 0.01 86.29 4 X 10 IU INFUSION | 1 0.01 86.30 4 X 10 IU INFUSIONS | 1 0.01 86.31 4.5 G IV Q 6 H, 4 D | 1 0.01 86.32 4.5 G IV Q8 H | 1 0.01 86.33 4.5 GRAM (TID), INTRAVENOUS | 1 0.01 86.34 4.5 MG BID PO | 1 0.01 86.35 4.5 MG, ONCE | 1 0.01 86.36 4.5 MG/D | 1 0.01 86.37 4.5 MIU, BID, SUBCUTAN | 1 0.01 86.38 4.7 MG/KG. INTRAVENOUS | 1 0.01 86.39 40 GM Q 4WEEKS INTRAVENOUS | 1 0.01 86.40 40 MG | 3 0.03 86.43 40 MG (40 MG, 1 TA OAD) PO | 1 0.01 86.44 40 MG (DAILY), ORAL | 1 0.01 86.45 40 MG 1X PER 1 DAY | 1 0.01 86.46 40 MG AT BEDTIME ORAL | 1 0.01 86.47 40 MG DAILY | 3 0.03 86.50 40 MG DAILY ORAL | 1 0.01 86.51 40 MG DAILY PO | 1 0.01 86.52 40 MG DAY ORAL | 1 0.01 86.53 40 MG IN A.M. AND 20 MG AT NIGHT. | 1 0.01 86.54 40 MG PO QD | 1 0.01 86.55 40 MG Q DAY, PO | 1 0.01 86.56 40 MG QD MRDC -TEVA-00093719856 | 1 0.01 86.57 40 MG QD MRDC TEVA -00093719856 | 1 0.01 86.58 40 MG QD ORAL | 2 0.02 86.60 40 MG QD PO | 2 0.02 86.62 40 MG TWICE DAIL ORAL | 1 0.01 86.63 40 MG TWICE DAILY ORAL | 1 0.01 86.64 40 MG, 1 IN 2 WK, SUBCUTANEOUS | 6 0.06 86.70 40 MG, 1 IN 2WK, SUBCUTANEOUS | 1 0.01 86.71 40 MG, QD, ORAL | 1 0.01 86.72 40 MG, SUBCUTANEOUS | 1 0.01 86.73 40 MG, TID, ORAL | 1 0.01 86.74 40 MG/BID, PO | 1 0.01 86.75 40 MG/D | 5 0.05 86.80 40 MG/DAY | 9 0.09 86.89 40 MG/DAY IV | 1 0.01 86.90 40 MG/DAY PO | 1 0.01 86.91 40 MG/DAY X 4 DAYS EVERY 28 DAYS, ORAL | 1 0.01 86.92 40 MG/M2 D1 + 8 Q21 INTRAVENOUS | 1 0.01 86.93 40 MG/M2 WEEKLY INTRAVENOUS | 1 0.01 86.94 40 PO QD | 1 0.01 86.95 40 TABLETS, SINGLE, ORAL | 1 0.01 86.96 40 U SC | 1 0.01 86.97 40 U/DAY | 1 0.01 86.98 40,000 IU WEEKLY SUBCUTANEOUS | 1 0.01 86.99 400 BID | 1 0.01 87.00 400 MCG, AS NECESSARY, RESPIRATORY (I.. | 1 0.01 87.01 400 MG (BID), ORAL | 2 0.02 87.03 400 MG (DAILY), INTRAVENOUS | 1 0.01 87.04 400 MG (DAILY), ORAL | 1 0.01 87.05 400 MG (QD) | 1 0.01 87.06 400 MG BID ORAL | 1 0.01 87.07 400 MG DAILY | 1 0.01 87.08 400 MG DAILY INTRAVENOUS | 1 0.01 87.09 400 MG DAILY ORAL | 1 0.01 87.10 400 MG EVERY 4 HO INTRAVENOUS | 1 0.01 87.11 400 MG QD INTRAVENOUS | 1 0.01 87.12 400 MG QD ORAL | 1 0.01 87.13 400 MG TABLET/DAY | 1 0.01 87.14 400 MG X 1 INTRAVENOUS | 1 0.01 87.15 400 MG, 2 IN 1 D, PER ORAL | 1 0.01 87.16 400 MG, 8 IN , INTRAVENOUS | 1 0.01 87.17 400 MG, BID | 1 0.01 87.18 400 MG, DAILY | 1 0.01 87.19 400 MG, IN 1 DAY, ORAL | 1 0.01 87.20 400 MG, INTRAVENOUS | 1 0.01 87.21 400 MG, ORAL | 2 0.02 87.23 400 MG, QD | 3 0.03 87.26 400 MG, TID | 1 0.01 87.27 400 MG/BID/PO | 1 0.01 87.28 400 MG/D | 11 0.11 87.39 400 MG/DAY | 5 0.05 87.44 400 MG/M2, ONCE , INTRAVENOUS BOLUS | 6 0.06 87.50 400 MG/M2, ONCE INTRAVENOUS BOLUS | 1 0.01 87.51 400 MG/M2, ONCE, INTRAVENOUS BOLUS | 1 0.01 87.52 400 MG/M2, ONCE, INTRAVENOUS BOLUS | 10 0.10 87.62 400 MG/M2, ONCE, INTRAVENOUS BOLUS; 4.. | 1 0.01 87.63 400 MG/M2, ONCE, INTRAVENOUS BOLUS; 4.. | 2 0.02 87.65 400 MG/M2, ONCE, INTRAVENOUS BOLUS; 4.. | 1 0.01 87.66 400 MG/M2, ONCE, INTRAVEOUS BOLUS | 1 0.01 87.67 400 MG; ORAL | 1 0.01 87.68 400 U SUBCUTANEOUS | 1 0.01 87.69 4000 MCG SQ X 5 DAYS | 1 0.01 87.70 4000 MG | 1 0.01 87.71 4000 U QD SC | 1 0.01 87.72 400; MG/M2, ONCE, INTRAVENOUS BOLUS; .. | 1 0.01 87.73 400MG IV PREOP | 1 0.01 87.74 400MG PER DAY | 5 0.05 87.79 400MG QD INTRAVENOUS | 1 0.01 87.80 400MG TWICE PER DAY | 2 0.02 87.82 400MG/DAY | 2 0.02 87.84 40MG PER DAY | 12 0.12 87.96 40MG, ORAL | 1 0.01 87.97 40MG/M2 D1+8Q21 INTRAVENOUS | 1 0.01 87.98 40MGML PER DAY | 1 0.01 87.99 40ML PER DAY | 1 0.01 88.00 42 MG | 1 0.01 88.01 420 MG, INTRAVENOUS | 1 0.01 88.02 4200MG QD IN 3 DO ORAL | 1 0.01 88.03 42MG PER DAY | 1 0.01 88.04 43MGK SEE DOSAGE TEXT | 1 0.01 88.05 440 MG PO BID-TID | 1 0.01 88.06 440 MG, TOTAL DAILY, ORAL | 1 0.01 88.07 45 MG, 1X/DAY, INTRAVENOUS | 1 0.01 88.08 45 MG, ONCE, PER ORAL | 1 0.01 88.09 45 MG/D | 3 0.03 88.12 45 MG; DAILY; INTRAVENOUS | 1 0.01 88.13 450 MG | 2 0.02 88.15 450 MG/DAY | 1 0.01 88.16 450 MG/M2/PER INFUSION | 1 0.01 88.17 450MG SEE DOSAGE TEXT | 2 0.02 88.19 450MG, ORAL | 1 0.01 88.20 480 MCG QD X 4 DAYS | 1 0.01 88.21 4G PER DAY | 1 0.01 88.22 4MG PER DAY | 10 0.10 88.32 4MG SINGLE DOSE | 1 0.01 88.33 4MG TWICE PER DAY | 4 0.04 88.37 4MG/DAY | 2 0.02 88.39 4UNIT PER DAY | 1 0.01 88.40 5 MG | 1 0.01 88.41 5 MG 1X PER 1 WK, ORAL | 1 0.01 88.42 5 MG BID ORAL | 1 0.01 88.43 5 MG DAILY | 1 0.01 88.44 5 MG DAILY ORAL | 2 0.02 88.46 5 MG M-W-F ORAL | 1 0.01 88.47 5 MG PO HS | 1 0.01 88.48 5 MG PO Q 5 PM | 2 0.02 88.50 5 MG PO QID | 1 0.01 88.51 5 MG Q DAY, PO | 1 0.01 88.52 5 MG TABLETS. | 1 0.01 88.53 5 MG X 4/1 5ML IV | 1 0.01 88.54 5 MG, 1 IN 1 D, PER ORAL | 1 0.01 88.55 5 MG, 2 IN 1 DAY, ORAL; 0.25 MG, 1 IN.. | 1 0.01 88.56 5 MG, BID | 1 0.01 88.57 5 MG, IN 1 DAY, ORAL | 1 0.01 88.58 5 MG, ONCE, | 1 0.01 88.59 5 MG, ORAL | 2 0.02 88.61 5 MG, QD | 4 0.04 88.65 5 MG, QD, ORAL | 1 0.01 88.66 5 MG/D | 1 0.01 88.67 5 MG/DAY | 8 0.08 88.75 5 MG/DAY PO | 2 0.02 88.77 5 MG/KG | 1 0.01 88.78 5 MG/KG, 1 IN 1 AS NECESSARY INTRAVEN.. | 1 0.01 88.79 5 MG/KG, 1 IN 1 AS NECESSARY, INTRAVE.. | 3 0.03 88.82 5 MG/KG, 1 IN 1 DAY, INTRAVENOUS | 1 0.01 88.83 5 MG/KG, 1 IN 1 DAY, INTRAVENOUS; 5 M.. | 1 0.01 88.84 5 MG/KG, 1 IN 8 WEEK, INTRAVENOUS | 1 0.01 88.85 5 MG/KG, INTRAVENOUS | 4 0.04 88.89 5 MG/KG, INTRAVENOUS DRIP | 1 0.01 88.90 5 MG/KG, INTRAVENOUS; INTRAVENOUS; IN.. | 1 0.01 88.91 5 MG/KG/D | 1 0.01 88.92 5 UG/KG/DAY (DAY 3 TO APHERESIS), SUB.. | 1 0.01 88.93 5 UG/KG/DAY/SQ | 1 0.01 88.94 5 VIALS; 5 VIALS; 5 VIALS | 1 0.01 88.95 5-60 MG''S PER MORNIN ORAL | 1 0.01 88.96 5-7 NG CONTNINUOUS | 1 0.01 88.97 5.5 MG/DAY | 1 0.01 88.98 50 IU/DAY | 1 0.01 88.99 50 MG | 1 0.01 89.00 50 MG (DAILY), ORAL | 4 0.04 89.04 50 MG (PRN), ORAL | 4 0.04 89.08 50 MG 1Q WK X 3 IV | 1 0.01 89.09 50 MG 1QDX 28 PO | 1 0.01 89.10 50 MG DAILY ORAL | 1 0.01 89.11 50 MG DAILY PO | 2 0.02 89.13 50 MG ONCE | 2 0.02 89.15 50 MG ONSET ORAL | 1 0.01 89.16 50 MG PO BID | 1 0.01 89.17 50 MG PO QD | 1 0.01 89.18 50 MG QD ORAL | 2 0.02 89.20 50 MG TID | 1 0.01 89.21 50 MG, 1 IN 1 D, ORAL | 1 0.01 89.22 50 MG, 2 IN 1 D, PER ORAL | 2 0.02 89.24 50 MG, 2 IN 1 DAY, ORAL | 2 0.02 89.26 50 MG, BID | 2 0.02 89.28 50 MG, QD | 1 0.01 89.29 50 MG, QD, ORAL | 1 0.01 89.30 50 MG/DAY | 5 0.05 89.35 50 MG/DAY PO/ A FEW MONTHS | 1 0.01 89.36 50 MG/M2 1 WEEK INTRAVENOUS NOS | 1 0.01 89.37 50 MG/M2 1/WEEK (CUMULATIVE DOSE : 60.. | 1 0.01 89.38 50 MG/M2 IV Q6 HOURS X 3 DOSES | 1 0.01 89.39 50 MG/M2 IVP ON DAY 3 | 1 0.01 89.40 50 MG/M2, WEEKLY, IV | 1 0.01 89.41 50 MG/M^2 1 X PER 1 CYCLE | 1 0.01 89.42 50 MG/M^2 1X PER 1 CYC, UNK | 3 0.03 89.45 50 MG/M^2 1X PER 1 CYCLE, UNK | 2 0.02 89.47 50 MG/M^2 BETWEEN 4-8 WEEKS GESTATION.. | 1 0.01 89.48 50 MG/M^2 BETWEEN 4-8 WKS GESTATION A.. | 1 0.01 89.49 50 U | 1 0.01 89.50 50 U/DAY | 1 0.01 89.51 50 UG/HR. 1 IN 72 HOUR, TRANSDERMAL | 1 0.01 89.52 50-600MG QD ORAL | 1 0.01 89.53 500 MG | 1 0.01 89.54 500 MG (BID), ORAL | 1 0.01 89.55 500 MG 2/D PO | 1 0.01 89.56 500 MG 4 TIME ORAL | 1 0.01 89.57 500 MG 4 TIMES ORAL | 1 0.01 89.58 500 MG BID ORAL | 1 0.01 89.59 500 MG BID PO | 1 0.01 89.60 500 MG DAILY | 1 0.01 89.61 500 MG IV OVER 4 H | 1 0.01 89.62 500 MG IVPB QD | 2 0.02 89.64 500 MG PO QD | 2 0.02 89.66 500 MG TID IV | 1 0.01 89.67 500 MG, 1 IN 1 D, ORAL | 1 0.01 89.68 500 MG, 1 IN 1 DAY, ORAL 3 | 1 0.01 89.69 500 MG, 1 IN 5 WEEK, INTRAVENOUS | 1 0.01 89.70 500 MG, 1 IN 8 WEEK, INTRAVENOUS | 1 0.01 89.71 500 MG, 2 IN 1 D, ORAL | 1 0.01 89.72 500 MG, 2 IN 1 D, PER ORAL | 1 0.01 89.73 500 MG, 2 IN 1 DAY, ORAL | 1 0.01 89.74 500 MG, BID | 1 0.01 89.75 500 MG, BID, ORAL | 1 0.01 89.76 500 MG, INTRAVENOUS | 1 0.01 89.77 500 MG, ORAL | 2 0.02 89.79 500 MG, TOTAL DAILY, ORAL | 1 0.01 89.80 500 MG/ DAILY; INTRAVENOUS | 1 0.01 89.81 500 MG/2 DAY | 1 0.01 89.82 500 MG/D | 2 0.02 89.84 500 MG/DAY | 1 0.01 89.85 500 MG}QID, ORAL | 1 0.01 89.86 500 ML/DAY | 1 0.01 89.87 500 UNITS PRN IM | 1 0.01 89.88 500 X1 IV | 1 0.01 89.89 500-650MG QD ORAL | 1 0.01 89.90 5000 UNITS ONCE | 1 0.01 89.91 5000/M2 OVER 24 HR INTRAVENOUS | 1 0.01 89.92 50000, QW | 1 0.01 89.93 500MG | 1 0.01 89.94 500MG AT BEDTIME ORAL | 1 0.01 89.95 500MG BD ORAL | 2 0.02 89.97 500MG DAILY ORAL | 1 0.01 89.98 500MG PER DAY | 3 0.03 90.01 500MG PO DAILY | 1 0.01 90.02 500MG THREE TIMES PER DAY | 2 0.02 90.04 500MG TWICE PER DAY | 2 0.02 90.06 500MG UNKNOWN | 1 0.01 90.07 500MG/DAY | 2 0.02 90.09 50G PER DAY | 1 0.01 90.10 50MG AS REQUIRED | 1 0.01 90.11 50MG IN THE MORNING | 1 0.01 90.12 50MG PER DAY | 4 0.04 90.16 50MG TWICE PER DAY | 2 0.02 90.18 50MG/DAY | 5 0.05 90.23 50U TWICE PER DAY | 1 0.01 90.24 52 U/DAY | 1 0.01 90.25 528, 545 IEQ ONE TIME O INTRAHEPATIC | 1 0.01 90.26 5280 MG, TOTAL DAILY, ORAL | 1 0.01 90.27 53 MG Q2WKS IV | 1 0.01 90.28 54 MG, 1X/DAY, INTRAVENOUS | 1 0.01 90.29 540 MG, TOTAL DAILY, INTRAVENOUS | 1 0.01 90.30 54MG PER DAY | 1 0.01 90.31 55 U DAY | 1 0.01 90.32 55 U/DAY | 1 0.01 90.33 56 MG/M2 INTRAVENOUS | 1 0.01 90.34 57 MG Q WEEK INTRAVENOUS | 1 0.01 90.35 57.3MG IV | 1 0.01 90.36 57.6 MG Q WEEK X 3 IV | 1 0.01 90.37 5G PER DAY | 1 0.01 90.38 5IU3 FOUR TIMES PER DAY | 1 0.01 90.39 5MCG PER DAY | 1 0.01 90.40 5MG 1/DAY ORAL | 1 0.01 90.41 5MG AT NIGHT | 1 0.01 90.42 5MG INTRAVENNOUS (NOS) | 1 0.01 90.43 5MG PER DAY | 9 0.09 90.52 5MG PO Q 5 PM, 7.5 MG PO Q 5 PM | 1 0.01 90.53 5MG THREE TIMES PER DAY | 2 0.02 90.55 5MG TID ORAL | 1 0.01 90.56 5MG TWICE PER DAY | 2 0.02 90.58 5MG/HR INTRAVENOUS | 1 0.01 90.59 5ML TWICE PER DAY | 1 0.01 90.60 5UG/KG SQ DAILY BEGINNING ON DAY 4 | 1 0.01 90.61 5UNIT TWICE PER DAY | 1 0.01 90.62 6 CAPSULE, 1 IN 1 D, PER ORAL | 1 0.01 90.63 6 G | 1 0.01 90.64 6 MG 1 X PER 1 WK, ORAL | 1 0.01 90.65 6 MG 1X PER 1 WEEK, ORAL | 1 0.01 90.66 6 MG DAILY | 1 0.01 90.67 6 MG, 1 IN 1 D, ORAL | 1 0.01 90.68 6 MG, 1IN 1 D, ORAL | 1 0.01 90.69 6 MG, 2 IN 1 D, SUBCUTANEOUS | 1 0.01 90.70 6 MG, BID | 4 0.04 90.74 6 MG, ORAL | 1 0.01 90.75 6 MG, QD | 1 0.01 90.76 6 MG, QD, PER ORAL | 1 0.01 90.77 6 MG/M2 1 DOSE OVER 2 HRS IV | 1 0.01 90.78 6 PO | 1 0.01 90.79 6 TABLETS/DAY | 2 0.02 90.81 6 U HS SC | 1 0.01 90.82 6 U, QD, ORAL | 1 0.01 90.83 6 U/DAY | 1 0.01 90.84 6 U/DAY PO | 2 0.02 90.86 6.5 MG Q WK X 3 | 1 0.01 90.87 6.75 GRAM (Q8H), INTRAVENOUS | 1 0.01 90.88 60 MG | 1 0.01 90.89 60 MG D1 ITNRAVENOUS | 1 0.01 90.90 60 MG DAILY ORAL | 1 0.01 90.91 60 MG IV, 50 MG IV | 1 0.01 90.92 60 MG ONCE PO | 1 0.01 90.93 60 MG ORAL @ NIGHT; A TOTAL OF 15 YRS.. | 1 0.01 90.94 60 MG TID | 1 0.01 90.95 60 MG, 1 IN 1 D, PER ORAL | 1 0.01 90.96 60 MG, 3 IN 1 D, PER ORAL | 1 0.01 90.97 60 MG, BID, ORAL | 1 0.01 90.98 60 MG/1 IN THE MORNING | 1 0.01 90.99 60 MG/D | 2 0.02 91.01 60 MG/DAY | 12 0.12 91.13 60 MG/M2, CYCLIC, IV | 1 0.01 91.14 60 U /KG Q2WKS IV | 1 0.01 91.15 60 U/2 DAY | 1 0.01 91.16 60 U/KG Q2WKS IV | 1 0.01 91.17 60 U/KG Q4WKS IV | 1 0.01 91.18 600 | 1 0.01 91.19 600 MG | 3 0.03 91.22 600 MG (BID), INTRAVENOUS | 1 0.01 91.23 600 MG DAILY PO | 1 0.01 91.24 600 MG IV Q 12 HRS | 1 0.01 91.25 600 MG IV Q 8 H | 1 0.01 91.26 600 MG ONCE PO | 1 0.01 91.27 600 MG Q DAY PO | 1 0.01 91.28 600 MG QD PO | 3 0.03 91.31 600 MG, 1 IN 1 D, PER ORAL | 1 0.01 91.32 600 MG, AT BEDTIME | 1 0.01 91.33 600 MG, BID | 2 0.02 91.35 600 MG, QD | 1 0.01 91.36 600 MG/ AT NIGHT | 1 0.01 91.37 600 MG/D | 1 0.01 91.38 600 MG/DAY | 4 0.04 91.42 600 MG/M2 INTRAVENOUS | 1 0.01 91.43 600 MG/M2, ONCE, INTRAVENOUS | 1 0.01 91.44 600 MG/M2, ONCE, INTRAVENOUS DRIP | 10 0.10 91.54 600 MG/M2,ONCE, INTRAVENOUS DRIP | 1 0.01 91.55 600 MG/TID, PO | 1 0.01 91.56 600 UNITS PRN IM | 1 0.01 91.57 600-900MG PO HS + 300 MG Q8H PRN | 1 0.01 91.58 600000 IU DAILY IV | 1 0.01 91.59 600MG HS ORAL | 1 0.01 91.60 600MG PER DAY | 6 0.06 91.66 600MG/M2 Q3WK X4 IV | 1 0.01 91.67 60MG PER DAY | 5 0.05 91.72 60MG TWICE PER DAY | 1 0.01 91.73 60MG/M2 Q3WK X 4 IV | 1 0.01 91.74 62.5MG/DAY | 1 0.01 91.75 625 MG ONCE, PO | 1 0.01 91.76 625 MG, 1 IN 1 DAY, ORAL | 1 0.01 91.77 63 MG 1/WEEK INTRAVENOUS NOS | 1 0.01 91.78 65 MG OTHER INTRAVENOUS DRIP | 1 0.01 91.79 65 MG WEEKLY IV | 1 0.01 91.80 65 MG, QD | 1 0.01 91.81 650/3832 MG, ONCE , ORAL | 1 0.01 91.82 650MG TWICE PER DAY | 1 0.01 91.83 65MG/M DAYS 1 AND IV | 1 0.01 91.84 67 MG ONCE PO | 1 0.01 91.85 68 MG, CYCLE 3, IV | 1 0.01 91.86 69.2MG DAY 1 AND INTRAVENOUS | 1 0.01 91.87 6G PER DAY | 3 0.03 91.90 6MG TWICE PER DAY | 1 0.01 91.91 6UNIT WEEKLY | 1 0.01 91.92 7 CYCLES: 21-NOV-01 TO MAR-02 (DAYS 1.. | 1 0.01 91.93 7 GMS IV | 1 0.01 91.94 7 MG, UNKNOWN/D, ORAL | 1 0.01 91.95 7 TABLET 1X PER 1 DAY, ORAL | 1 0.01 91.96 7-8 DAY | 1 0.01 91.97 7.5 % ICODEXTRIN 2L QD IP | 1 0.01 91.98 7.5 MCG QW IM | 2 0.02 92.00 7.5 MG (ONCE DAILY) PO | 1 0.01 92.01 7.5 MG / DAY | 1 0.01 92.02 7.5 MG AT 11:45 AM AND 7.5 MG AT 9 PM | 1 0.01 92.03 7.5 MG AT 11:45AM. 7.5 MG AT 9 PM | 1 0.01 92.04 7.5 MG DAILY PO | 1 0.01 92.05 7.5 MG QW IV | 4 0.04 92.09 7.5 MG, IN 1 WEEK, | 1 0.01 92.10 7.5 MG, 1 IN 1 DAY, ORAL | 1 0.01 92.11 7.5 MG, PRN, ORAL | 1 0.01 92.12 7.5 MG/DAY | 2 0.02 92.14 7.5 TO 20 MG WEEKLY, ORAL | 1 0.01 92.15 7.5% ICODEXTRIN 2L QD IP | 1 0.01 92.16 70 QW | 1 0.01 92.17 70 MG / DAY | 1 0.01 92.18 70 MG/M2 ON DAY 1 AND DAY 8; INTRAVEN.. | 1 0.01 92.19 700 MG, 1 IN 1 D, PER ORAL; 300 MG, 1.. | 1 0.01 92.20 70MG PER DAY | 1 0.01 92.21 720 MG, BID | 1 0.01 92.22 75 /MG/M2 WEEKLY INTRAVENOUS | 1 0.01 92.23 75 MG | 1 0.01 92.24 75 MG (ONCE DAILY) PO | 1 0.01 92.25 75 MG (TID), ORAL | 1 0.01 92.26 75 MG (TID), PLACENTAL | 2 0.02 92.28 75 MG / DAY | 3 0.03 92.31 75 MG 1X PER 1 DAY, ORAL | 1 0.01 92.32 75 MG 2XDAY-TID ORAL | 1 0.01 92.33 75 MG 3X DAY ORAL | 1 0.01 92.34 75 MG DAILY | 1 0.01 92.35 75 MG DAILY ORAL | 1 0.01 92.36 75 MG INTRALESIONAL | 1 0.01 92.37 75 MG OD ORAL | 1 0.01 92.38 75 MG ORAL | 1 0.01 92.39 75 MG PO QAM | 1 0.01 92.40 75 MG QD | 1 0.01 92.41 75 MG QD - ORAL | 1 0.01 92.42 75 MG QD, ORAL | 1 0.01 92.43 75 MG QD; ORAL | 1 0.01 92.44 75 MG, 1 IN 1 D | 1 0.01 92.45 75 MG, OD, ORAL | 1 0.01 92.46 75 MG, ONCE/SINGLE | 1 0.01 92.47 75 MG, ORAL | 1 0.01 92.48 75 MG, PER ORAL | 1 0.01 92.49 75 MG, QD, ORAL | 1 0.01 92.50 75 MG, QD, UNK | 1 0.01 92.51 75 MG/D | 2 0.02 92.53 75 MG/DAY | 1 0.01 92.54 75 MG/M2 | 3 0.03 92.57 75 MGS 1 AT BEDTI ORAL | 1 0.01 92.58 75 ML, ONCE | 1 0.01 92.59 75 UG QD PO | 1 0.01 92.60 75 UG/HR, 1 IN 48 HOUR, INJECTION | 1 0.01 92.61 750 MG DAILY PO | 1 0.01 92.62 750 MG IV | 1 0.01 92.63 750 MG TID /750 MG BID | 1 0.01 92.64 750 MG, 1 IN 1 DAY | 1 0.01 92.65 750IU PER DAY | 1 0.01 92.66 750MG PER DAY | 2 0.02 92.68 75MCG PER DAY | 1 0.01 92.69 75MG ORAL | 1 0.01 92.70 75MG PER DAY | 7 0.07 92.77 75MG THREE TIMES PER DAY | 2 0.02 92.79 75MG TWICE PER DAY | 1 0.01 92.80 75MG/DAY | 1 0.01 92.81 75MG/M2 Q 3 WEEKS INTRAVENOUS | 1 0.01 92.82 76 U/DAY | 4 0.04 92.86 760 MG, Q2W | 1 0.01 92.87 770 MG/DAY | 1 0.01 92.88 79 DF ONCE PO | 2 0.02 92.90 8 0 MG, ONCE | 1 0.01 92.91 8 MG 1X PER 1 WEEK, ORAL | 1 0.01 92.92 8 MG DAILY PO | 1 0.01 92.93 8 MG, 2 IN 1 DAY, ORAL | 1 0.01 92.94 8 MG, BID | 1 0.01 92.95 8 MG/DAY | 1 0.01 92.96 8 MIU, EVERY 2 D, SUBCUTANEOUS | 1 0.01 92.97 8 MIU, EVERY 2 D, HS, SUBCUTANEOUS | 1 0.01 92.98 8 MIU, EVERY 2D, SUBCUTANEOUS | 2 0.02 93.00 80 MCG QWK SUBCUTANEOUS | 1 0.01 93.01 80 MG DAILY PO | 1 0.01 93.02 80 MG TWICE DAILY ORAL | 1 0.01 93.03 80 MG, ONCE | 1 0.01 93.04 80 MG, Q12H, ORAL | 2 0.02 93.06 80 MG, QD | 3 0.03 93.09 80 MG, SEE TEXT, ORAL; 20 MG, SEE TEX.. | 1 0.01 93.10 80 MG, TID | 1 0.01 93.11 80 MG, WKLY X 6, IV | 1 0.01 93.12 80 MG/D | 1 0.01 93.13 80 MG/DAY | 6 0.06 93.19 80 U/DAY | 1 0.01 93.20 80-40-0 MG PO | 1 0.01 93.21 800 MCG, VAGINAL | 1 0.01 93.22 800 MG (NR, TWICE DAILY) | 1 0.01 93.23 800 MG ONE TIME INTRAVENOUS | 1 0.01 93.24 800 MG QD PO | 1 0.01 93.25 800 MG QWK SUBCUTANEOUS | 1 0.01 93.26 800 MG, BID | 1 0.01 93.27 800 MG,QD, ORAL | 1 0.01 93.28 800 MG./M2/OTHER | 1 0.01 93.29 800 MG/DAY | 3 0.03 93.32 800 MG/M2 IV Q 21 D | 1 0.01 93.33 800 MG/THREE TIMES PER DAY/ORAL | 1 0.01 93.34 800 UG 1X PER 1 CYCLE | 1 0.01 93.35 800 UG 1X PER 1 CYCLE, UNK | 3 0.03 93.38 800 UG 1X PER 1CYC,UNK | 1 0.01 93.39 800 UG 1X PER CYCLE UNK | 1 0.01 93.40 800 UNITS Q2WKS IV | 1 0.01 93.41 8000 IU (8000 IU, 1 IN 1 D), SUBCUTAN.. | 1 0.01 93.42 800MG PER DAY | 3 0.03 93.45 80MG PER DAY | 3 0.03 93.48 80MG THREE TIMES PER DAY | 1 0.01 93.49 80MG/DAY | 3 0.03 93.52 81 MG PO QD | 1 0.01 93.53 81 MG, QD | 3 0.03 93.56 81 MG, UNK | 1 0.01 93.57 81 MG/DAY | 1 0.01 93.58 81MG PER DAY | 3 0.03 93.61 825 MG/M2 TWICE DAILY FOR 5 DAYS OF W.. | 1 0.01 93.62 83 UG/KG /MIN IV | 1 0.01 93.63 84 MG IV Q3 WKS X 3 | 1 0.01 93.64 85 MG/M2 AS A 2 HOURS IV INFUSION ON .. | 1 0.01 93.65 850 MG PO THREE TIMES A DAY | 1 0.01 93.66 86 U/DAY | 1 0.01 93.67 8MG PER DAY | 1 0.01 93.68 8UNIT PER DAY | 1 0.01 93.69 9 MG/DAY | 1 0.01 93.70 9 MG/M^2 1X PER 1 DAY, INTRAVENOUS | 1 0.01 93.71 9 MIU, | 1 0.01 93.72 9 MIU/M2 BID, DAYS 1-2, WK 1 + 3, SUB.. | 1 0.01 93.73 9 MIU/M2, BID, D1-2, WKS 1+3, SUBCUTA.. | 1 0.01 93.74 9 TAB ONCE PO | 2 0.02 93.76 9 U/DAY | 1 0.01 93.77 9.6 MG, WEEKLY | 1 0.01 93.78 90 MG DAILY ORAL | 2 0.02 93.80 90 MG, 1 IN 30 D, INTRA-MUSCULAR | 1 0.01 93.81 90 MG, DAILY, ORAL | 1 0.01 93.82 90 MG, UNK | 1 0.01 93.83 90 MG/DAY | 1 0.01 93.84 900 MG | 4 0.04 93.88 900 MG (DAILY), | 1 0.01 93.89 900 MG (DAILY), ORAL | 1 0.01 93.90 900 MG (TID), ORAL | 3 0.03 93.93 900 MG DAILY PO | 1 0.01 93.94 900 MG QD ORAL | 1 0.01 93.95 900 MG, QD | 1 0.01 93.96 9000 U INTRAMUSCULAR | 1 0.01 93.97 900MG TWICE A WEEK | 1 0.01 93.98 90MG PER DAY | 1 0.01 93.99 93 MG PER DAY SUBCONJUNCT | 1 0.01 94.00 95 MG; DAILY; INTRAVENOUS | 1 0.01 94.01 950 MG; DAILY; INTRAVENOUS | 1 0.01 94.02 96 MCG QWE SUBCUTANEOUS | 1 0.01 94.03 960 MG Q WEEK X 3 IV | 1 0.01 94.04 978 MG, CYLIC, IV | 1 0.01 94.05 9MIU | 1 0.01 94.06 @ 1.5 AUC IV WEEKLY | 1 0.01 94.07 @1.5 AUC IV WEEKLY | 1 0.01 94.08 A FEW HOURS | 1 0.01 94.09 ACTUAL DOSE RECIEVED WAS 1800 MG BID .. | 1 0.01 94.10 ACTUAL DOSE RECIVED WAS 240 MG ADMINI.. | 1 0.01 94.11 ACU 5 IV Q 21D | 1 0.01 94.12 ADDITIONAL DOSE GIVEN ON 26-NOV-03 | 1 0.01 94.13 ADMINISTERED QHS. | 1 0.01 94.14 ALCOHOL WITHDRAWAL SYNDROME | 1 0.01 94.15 ALTERNATING 1200 MG/D AND 900 MG/D | 1 0.01 94.16 AOC-2 D1+8 Q21 | 1 0.01 94.17 AUC 2 | 1 0.01 94.18 AUC 5.0 Q 3 WKS X 8 IV | 1 0.01 94.19 AUC 6 | 1 0.01 94.20 AUC = 6 | 1 0.01 94.21 AUC =6 IV Q 3 WKS | 1 0.01 94.22 AUC=2 D1+8 Q21 INTRAVENOUS | 1 0.01 94.23 BLINDED | 2 0.02 94.25 CAPECITABINE 2000MG/M2 PO | 1 0.01 94.26 CAPECITIBINE D 1-14 | 1 0.01 94.27 CAPSULE | 3 0.03 94.30 CARPUJECT | 1 0.01 94.31 CELEBREX QD | 1 0.01 94.32 COG#9761 | 1 0.01 94.33 COURSE 1 RECEIVED ON 19-JUL-2002 | 1 0.01 94.34 CPT-11 D 1 AMD 8 Q 21 DAYS | 1 0.01 94.35 CYCLE 1: 01-NOV-02 CYCLE 2: STARTED .. | 2 0.02 94.37 CYCLE 2: STARTED AT A 50% REDUCED DOS.. | 1 0.01 94.38 CYCLIC | 2 0.02 94.40 D | 1 0.01 94.41 DAILY | 1 0.01 94.42 DAILY DOSE INCREASED TO 0.4 MG ON 07 .. | 1 0.01 94.43 DAILY ORAL | 2 0.02 94.45 DAILY ORAL INTAK LOWEST RECOMMEDED DOSE | 1 0.01 94.46 DAILY, ORAL | 1 0.01 94.47 DAY 1 - 2 DAY 3 THRU ORAL | 1 0.01 94.48 DAY 1 AND DAY 3 | 1 0.01 94.49 DAY 1 TO DAY 3 | 1 0.01 94.50 DAY 2 WITH 1RST COURSE 21-NOV-01 TO M.. | 1 0.01 94.51 DAY 3 | 1 0.01 94.52 DAYS 1-3 | 2 0.02 94.54 DOSAGE 30MCI | 1 0.01 94.55 DOSAGE REGIMEN REPORTED AS: 30 M.V. | 1 0.01 94.56 DOSAGE REPORTED AS: ONE VIAL. | 1 0.01 94.57 DOSAGE: 12.75 MCI FOR THE STRESS PORT.. | 1 0.01 94.58 DOSAGE: 1ST DOSE: 11.1 MCI - REST STU.. | 1 0.01 94.59 DOSE 20 (UNIT UNSPECIFIED) PER DAY. | 1 0.01 94.60 DOSE ON 16-OCT-2003 WAS 210 MG. | 1 0.01 94.61 DOSE ON 16-OCT-2003 WAS 500 MG | 1 0.01 94.62 DOSE REPORTED AS 2 G CONTINUOUS. | 1 0.01 94.63 DOSE REPORTED AS 200 MG CONTINUOUS. | 1 0.01 94.64 DOSE REPORTED AS 200 ML CONTINUOUS. | 1 0.01 94.65 DOSE REPORTED AS 3 MG CONTINUOUS. | 1 0.01 94.66 DOSE REPORTED AS 30 MG CONTINUOUS. | 1 0.01 94.67 DOSE REPORTED AS 40 MG CONTINUOUS. | 1 0.01 94.68 DOSE REPORTED AS 8 MG CONTINUOUS. | 1 0.01 94.69 DOSE TAKEN IN AM | 3 0.03 94.72 DOSE TAKEN IN AM AND PM | 1 0.01 94.73 DOSE TAKEN IN PM | 2 0.02 94.75 DOSE VALUE: 31-34 MCI | 1 0.01 94.76 DOSE VALUE: 0.05 CC 2% | 1 0.01 94.77 DOSE: 1-2 PUFFS | 1 0.01 94.78 DOSE: 1A | 1 0.01 94.79 DOSE: 22-3 | 1 0.01 94.80 DOSE: 3 GY | 1 0.01 94.81 DOSE: 300 EVERY 6-8 WEEKS | 1 0.01 94.82 DOSE: 5/20 | 1 0.01 94.83 DOSE: 5040 CGY | 1 0.01 94.84 DOSE: 5MG/WEEK | 2 0.02 94.86 DOSE: 6MG/WEEK | 1 0.01 94.87 DOSE: 75 (X2) | 1 0.01 94.88 DOSE: N-100/650 (1 TAB) | 1 0.01 94.89 DOSE: NONE | 1 0.01 94.90 DOSE: NOT PROVIDED | 4 0.04 94.94 DOSE: UNK | 12 0.12 95.06 DOSE=1-2 MG; 4 MG, IN 1 DAY, ORAL | 1 0.01 95.07 DOSING REGIMEN REPORTED AS Q WEEKLY. | 1 0.01 95.08 DOSING REGIMEN REPORTED AS QD. | 2 0.02 95.10 DOSING: 27MCI | 1 0.01 95.11 DRUG REPORTED AS BELOC COR. | 1 0.01 95.12 DS ONE DOSE PO BID | 1 0.01 95.13 DURATION: 5 CYCLES | 1 0.01 95.14 DURATION: MANY YRS; INTERRUPTED 10FEB.. | 1 0.01 95.15 EVERY AM | 1 0.01 95.16 FOETAL DRUG EXPOSURE VIA FATHER | 1 0.01 95.17 FOR 14 DAYS FOLLOWED BY 7 DAYS REST | 1 0.01 95.18 FROM MONDAY TO FRIDAY. | 1 0.01 95.19 GIVEN 2 ONLY | 1 0.01 95.20 GIVEN ON DAY ONE OF A THREE WEEK CYCLE. | 1 0.01 95.21 GM-CSF 12/20-1 2/3 SUBCUTANEOUS | 1 0.01 95.22 GROUP B | 1 0.01 95.23 HAS BEEN TREATED EVERY EIGHT WEEKS FO.. | 1 0.01 95.24 I G | 1 0.01 95.25 IN 1 AS NECESSARY, INTRAVENOUS DRIP | 1 0.01 95.26 IN 1 AS NECESSARY, INTRAVENOUS DRIP; .. | 1 0.01 95.27 INCREASED DOSE | 1 0.01 95.28 INHALATION | 2 0.02 95.30 INITIAL DATE OF THERAPY: 29-JUL-2002... | 1 0.01 95.31 INITIAL DOSE 17APR02. ADD'L LOTS: 1A3.. | 1 0.01 95.32 INITIAL DOSE-2 TABLETS THREE TIMES DA.. | 1 0.01 95.33 INITIAL DOSE: 150 MG DAILY; DOSAGE IN.. | 1 0.01 95.34 INITIAL THERAPY DATE: 29-JUL-2002. ST.. | 1 0.01 95.35 INJECTABLE | 12 0.12 95.47 INJECTION DENTAL | 1 0.01 95.48 INTERMITTENT THERAPY GIVEN WEEKLY FOR.. | 1 0.01 95.49 INTERMITTENT THERAPY OF TWO WEEKS THE.. | 1 0.01 95.50 INTERMITTENT THERAPY OF TWO WEEKS TRE.. | 1 0.01 95.51 INTERMITTENT THERAPY OF TWO WEEKS TRE.. | 1 0.01 95.52 INTRAMUSCULAR | 10 0.10 95.62 INTRAVENOUS | 45 0.45 96.07 INTRAVENOUS NOS | 3 0.03 96.10 INTRAVENOUS; INTRAVENOUS | 2 0.02 96.12 IRINOTECAN IV 115 MG /M2 | 1 0.01 96.13 IV | 6 0.06 96.19 IV Q 1 H | 1 0.01 96.20 IX/IV | 1 0.01 96.21 LESS THAN 1 MONTH | 1 0.01 96.22 LESS THAN 5M Q.D. ORAL | 1 0.01 96.23 LEVEL 1 | 1 0.01 96.24 LEVEL 2 | 1 0.01 96.25 LEVEL 3 | 1 0.01 96.26 LEVEL 4 | 1 0.01 96.27 LEVEL 5 | 1 0.01 96.28 LIQUID | 1 0.01 96.29 LONG TERM (TAKEN FOR }12 MONTHS) | 4 0.04 96.33 LONGSTANDING | 2 0.02 96.35 MAX DOSE 1 PER DAY ORAL | 1 0.01 96.36 MCG | 1 0.01 96.37 MCG, DAILY, INTRATHECAL | 1 0.01 96.38 MULTIPLE DAY | 1 0.01 96.39 MULTIPLE DAY SC | 1 0.01 96.40 MULTIPLE DAY SUBCUTANEOUS | 1 0.01 96.41 MWF/STWKS | 1 0.01 96.42 NO TREATMENT | 2 0.02 96.44 NOT REPORTED | 3 0.03 96.47 NOV-2002 TO NOV-2003: 150 MG DAILY; N.. | 1 0.01 96.48 NUMBER OF COURSES: 2 | 1 0.01 96.49 NUMBER OF DOSAGES: ^2 + 2^ | 1 0.01 96.50 ON DAYS 1 AND 8 OF A 3 WEEK CYCLE. | 1 0.01 96.51 ON DAYS 1-5, 8-12 OF A TWO WEEK CYCLE | 1 0.01 96.52 ONCE PO BID | 1 0.01 96.53 ONCE A DAY, AT NIGHT | 1 0.01 96.54 ONCE BID | 1 0.01 96.55 ONCE DAILY | 1 0.01 96.56 ONCE NIGHTLY ORAL | 1 0.01 96.57 ONCE WEEKLY ORAL | 1 0.01 96.58 ONCE, INTRAVENOUS | 3 0.03 96.61 ONE A DAY | 1 0.01 96.62 ONE DAILY | 1 0.01 96.63 ONE PO QD WITH MEALS | 1 0.01 96.64 ONE PUFF AM AND PM | 1 0.01 96.65 ONE QD | 1 0.01 96.66 ONE TAB TWICE DAY ORAL | 1 0.01 96.67 ONE TAB/DA | 1 0.01 96.68 ONE TABLET - WEEKLY | 1 0.01 96.69 ONE TABLET DAILY ORAL | 1 0.01 96.70 ONE TABLET TWICE A DAY | 2 0.02 96.72 ONE WEEK | 1 0.01 96.73 ONE/DAY | 1 0.01 96.74 ORAL | 90 0.90 97.64 ORAL; SEE IMAGE | 1 0.01 97.65 ORALLY TWICE/DAY | 1 0.01 97.66 OTHER | 2 0.02 97.68 PER ORAL | 8 0.08 97.76 PILLS, ORALLY 2X A DAY | 1 0.01 97.77 PO | 53 0.53 98.30 PO BID | 3 0.03 98.33 PRN | 4 0.04 98.37 QD | 2 0.02 98.39 QD PO | 3 0.03 98.42 QD, INTRAVENOUS | 1 0.01 98.43 QOD,ORAL | 1 0.01 98.44 R | 1 0.01 98.45 RECEIVED BOTH THE REST AND STRESS DOS.. | 1 0.01 98.46 RECEIVING INFLIXIMAB OVER A YEAR | 1 0.01 98.47 REPORTED AS: DAKOTA 500M. | 1 0.01 98.48 REPORTED AS: MERCK. | 1 0.01 98.49 ROUTE OF ADMINISTRATION: INJECTION | 1 0.01 98.50 ROUTE OF ADMINISTRATION: INTRAVENOUS .. | 1 0.01 98.51 ROUTE REPORTED AS DRIP. STRENGTH REPO.. | 1 0.01 98.52 ROUTE WAS VIA DRIP. | 1 0.01 98.53 ROUTE: INJECTION | 2 0.02 98.55 ROUTE: ^INJECTION.^ SECOND ^STRESSS^ .. | 1 0.01 98.56 ROUTE: ^INJECTION^ | 1 0.01 98.57 ROUTE: ^INJECTION^ FIRST DOSE: 9.4 M.. | 1 0.01 98.58 SC | 1 0.01 98.59 SEE IMAGE | 1 0.01 98.60 SEE DOSAGE TEXT/ | 1 0.01 98.61 SEE IMAGE | 47 0.47 99.08 SEE TEXT | 1 0.01 99.09 SIX OR SEVEN 25 MG TABLETS DAILY, ORAL | 1 0.01 99.10 SOLUTION | 1 0.01 99.11 START DATE 25-MAY (YEAR UNSPECIFIED) | 1 0.01 99.12 STARTED PRIOR TO THE 4TH COURSE | 1 0.01 99.13 STOP DATE OF THERAPY: 26-AUG-2002. | 1 0.01 99.14 SUBCUTANEOUS | 7 0.07 99.21 TABLET | 14 0.14 99.35 TABLET 1 X DAY | 1 0.01 99.36 TABLET 1X DAY | 1 0.01 99.37 TAKE 2 | 1 0.01 99.38 TAKEN WEEKLY | 1 0.01 99.39 TAKEN WEEKLY. STRENGTH REPORTED AS 18.. | 1 0.01 99.40 THERAPY DATES: 15-JUL-2003 | 1 0.01 99.41 THERAPY DURATION: 1-2 MONTHS | 1 0.01 99.42 THERAPY START DATE 23-SEP-2003 | 2 0.02 99.44 TID PO | 1 0.01 99.45 TITRATED UP TO 300MG (OVER 4 WEEKS) | 1 0.01 99.46 TOP | 1 0.01 99.47 TOPICAL | 1 0.01 99.48 TRANSDERMAL | 6 0.06 99.54 TWICE DAY | 1 0.01 99.55 TWO 200 MG CAPSULES | 1 0.01 99.56 UNIT: MG/HR | 1 0.01 99.57 UNK | 2 0.02 99.59 UNK, INTRAPERITONEAL (IP) | 1 0.01 99.60 UNK, ONCE/SINGLE | 2 0.02 99.62 UNK, PRN | 3 0.03 99.65 UNK, QD | 1 0.01 99.66 UNK, UNK | 6 0.06 99.72 UNK, UNKNOWN/D, ORAL | 1 0.01 99.73 UNK, UNKNOWN/D, UNKNOWN | 2 0.02 99.75 UNK,UNK | 2 0.02 99.77 UNK/UNK | 1 0.01 99.78 UNKNOWN | 6 0.06 99.84 UNKNOWN (BID), ORAL | 1 0.01 99.85 UNKNOWN DATE: INCREASED TO 40 MG DAILY | 1 0.01 99.86 UNKNOWN DOSE THREE TIMES WEEKLY, ORAL | 1 0.01 99.87 UNKNOWN, 1 IN 30 D, INTRA-MUSCULAR | 1 0.01 99.88 UNSPECIFIED | 4 0.04 99.92 VAGINAL | 1 0.01 99.93 VARIABLE ORAL | 1 0.01 99.94 VARIED PER MORNIN ORAL | 1 0.01 99.95 VARIED PER MORNING ORAL | 1 0.01 99.96 VARIOUS-RECEIVED PO 20 MG OVER 48 H A.. | 1 0.01 99.97 ^1 PILL AT A TIME, APPROXIMATELY 3 WI.. | 1 0.01 99.98 ^1 TABLET/DAY 1 DAY OF 2 DAYS + OTHER.. | 1 0.01 99.99 ^2 TEASPOONS/APPROX 8 WITHIN 24-HOURS.. | 1 0.01 100.00 ----------------------------------------+----------------------------------- Total | 10,000 100.00 by Jean Roth , jroth@nber.org , 18 Dec 2015